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Leprosy besides being important as a serious cause of 
morbidity and mortality in under—developed countries, continues to 
produce social ostracism and fascinates biologis ts . This i s because 
of t h e unique range of host paras i te interactions between man and 
Mf'Go^bad.erium leprae . Org Polar form of leprosy is characterized by 
high cellular Immunity and res t r ic ted disease , whereas t he other form 
shows absence of cellular Immunity to t h e pa ras i t e , and paradoxi-
cally hyper - reac t iv i ty of t h e humoral immune system to al l antigens. 
Leprosy afflictions go thr.qugh phases . The greater part of 
t he population having contact with patients with mult i_baci l lary forms 
of leprosy may be infected. The defense (Immune status) in most cases 
will limit and arrest t h e multiplication of leprosy baci l l i before 
signs of t h e disease appear . In some individuals t h e disease will 
progress to clinical forms of leprosy which var ies from tuberculoid 
(TT-BT) leprosy to lepromatous (BL-LL) leprosy . The last form i s 
the most infectious and has t h e longest incubation per iod . 
The screening programmes to detect cases of leprosy started 
long back in t h e leprosy endemic a reas . But t h e progress has been 
and s t i l l i s hamperdd by dificulties encountered in t h e diagnosis of 
early leprosy and leprosy in t h e incubation per iod . 
A readi ly available and chemically characterized leprosy spec i -
fic antigen namely phenolic glycolipidof M.leprae would be a valuable 
tool for diagnosis and t'alicenomic s tudies . Despite; t h e sensi t ivi ty and 
specificity attached to t h i s antigen, it- would be difficult to procure 
it since t h e source of M.leprae itself i s limited and is constantly 
dying out due tomassire.-Shnont.Therefore, some al ternat ives have to 
be thought of. If some antigenlcally related a typica l mycobacteria 
which is capable of detecting t h e same or appropriate percentage 
of cases of leprosy l ike that of M.leprae glycolipid. i s sorted out 
t he problem of scarci ty of antigenic avai labi l i ty may be abbrevia ted . 
Our laboratory has been working from t h e past several years 
on an antigenically related strain of Mycobacterium/designated M.habana. 
Its poss ibi l i ty to detect a n t i - l e p r o s y antibodies in humans 
through cell sonication or in particulate state may provide some useful 
information regarding t h e diagnosis of leprosy . 
This study has been under taken f o r : -
I ( a ) . Detection of M.leprae specific antibodies through ELISA test 
using part iculate M.leprae antigen as control. 
( b ) . Comparison of M.habana antigen through ELISA tes t to detect 
M.leprae antibodies in t h e sera samples of leprosy pa t ien ts . 
2. Patterns of Immunoglobulin in t h e sera of leprosy pat ients . 
3 . Total serum protein and Albumin/Globulin estimations in t h e sera 
samples of various grades of leprosy and i t s comparison with t ube r -
culosis patient sera . 
4. Serum enzyme profile during various phases of leprosy along with 
healthy individuals . 
Enzyme linked Immunosorbent Assay 
Since diagnostic values of M.habana antigen was precis ly 
not known in detection of M. leprae antibodies from human patient 
sera , t h i s test was conducted using different preprat ions of M.habana» 
We have used t h i s Mycobacterium in t h r ee physical s ta tes . The l ive , 
t h e V i r r ad ia t ed and t h e sonicated one and have compared with whole 
cell antigen. 
In our test system we used t h e sera samples in two different 
ways. In one system we used unabsorbed sera and in other t h e absorb-
ed one. Various antigens used to make the serum nearly monospecific 
comparised of Lecithin, Cardiol ipin, M.bovis (BCG p h i p p s ) , M.tubercul-
- s i s H-,„Ra and M.vaccae. 
The l ive baci l l i of M.habana and Virradia ted bac i l l i of t he 
same strain had precis ly no descernible difference in detecting t he 
leprosy antibody-" in patients sera . The same bacter ia l antigen in 
sonicated state has lost some of i t s proper ty in detecting M. leprae 
antibodies in TT, BT and BB cases and at Mean+3SD cut point it could 
detect antibodies in only BL and LL patients sera which are known 
to contain high concentration of ant ibodies . Thus low levels of antibod-
ies were not easily detectable by sonicated M.habana antigens. 
M.habana antigen in e i ther form ( l ive and V" i r rad ia ted) was 
able to detect M.leprae antibody in both unabsorbed and absorbed 
sera samples to a considerable extent . The removal of group specific 
antibodies in t h e serum samples had l i t t l e effect and M.habana antigen 
was capable of detecting considerably high percentage of posi t ive 
leprosy cases par t icular ly from upgrading side of t h e spectrum of 
leprosy. 
The absorption of t h e sera samples with specific and non-
specific antigen does seem only to have some effect in detecting only 
few cases in down—grading reactionary state that i s TT and BT forms. 
The resul ts have indicated that besides group specific antigens to 
mycobacteria, M.habana does possess some more common antigenic 
determinants to M.leprae that i s why it i s capable of detecting almost 
similar percentage of cases of leprosy as i s being done by M.leprae. 
The )^irradiated antigen was sl ightly bet ter over l ive b a c i l l i . 
When t h e tuberculosis patients sera samples were absorbed 
with specific and non specific antigens including M.tuberculosis H_„Ra 
ant-igen t h e sensi t ivi ty of M.habana to detect M.tuberculosis antibodies 
was considerably lowered and at Mean+2SD and Mean+3SD cut of point 
no TB cases could be detected by M.habana antigens, even at Mean+SD 
cut off point t h e E .Q_ values in tuberculosis patients absorbed sera 
was considerably low. 
Irv ^Comparison t h e two antigens namely M.leprae part iculate 
and M.habana part iculate seem to have closer relat ionship in detecting 
M. leprae antibodies even after absorption of non-specif ic antibodies 
from t h e sera samples of leprosy cases. 
Tmmunop;lobii1in Pattern in Serum 
Serum Immunoglobulins were estimated by single radial Immuno-diffu-
sidri technique and resul ts were compared among various groups of 
leprosy patients having treatment 6 months to 5 years with DDS. 
Most of t he serum immunoglobulins classes are increased in 
leprosy patients against control groups. But a marked decreased serum 
IgG, IgM and increase in ]gA was found in pat ients t rea ted with 2 to 
5 years with DDS when compared with group t rea ted 6 months to 
2 years with DDS. 
Total Serum Protein Albumin: Globulin Ratio 
A comparison of to ta l serum proteins albumin and globulin 
ratio along with different fraction of globulins from t h e leprosy patient 
sera covering t h e entire spectrum of leprosy and tuberculosis has 
been made. There has been a considerable increase of the over al l 
to ta l serum proteins of leprosy and tuberculosis patients over normal 
controls. The albumin value has shown a decline over globulin value 
and t h e level of gamma—globulins has indicated significant degree of 
elevation in leprosy patient sera indicating t h e outplay of humoral 
response. The A/G rat io in leprosy has shown a declining t rend in 
values as t h e spectrum moves from TT to LL s ide . 
Serum Enzyme Profile 
Serum Enzyme Profile wasstudiedin 80 patients with different 
clinical grades of leprosy and compared with that of 25 healthy controls. 
The enzyme studied were SGOT, SGPT, LDH (Total) acid and alkaline 
r 
phosphatase. SCOT shows a decreasing t rend from TT to BL but an 
elevated level has been found in LL cases as compared to normal. 
Contrary to t h i s an increasing pattern was recorded in t he case of 
SGPT from TT to LL against control value, except TT which shows 
a decreased level over control. Serum LDH (total) was found significan-
t l y elevated in BB, BL and LL but t h e r e i s no significant difference 
in TT and BT when compared with t he control values. Serum acid 
and alkaline phsophatases showed fluctuating t rend in different grades 
of leprosy against normal control values . 
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INTRODUCTION 
Tuberculosis and leprosy today, are the major health problems 
in the tropical and subtropical world. Both are chronic diseases , caused 
by Mycobacteria and a re , our greatest enemy which have afflicted the 
world from centuries. 
Leprosy was the f i rs t human bacterial disease recognized by 
a Narwegian Scientist Armauer Hansen working in Bergen in 1873. He identi-
fied the bacteria microscopically in the tissues of patients with leprosy. 
This was at a time when human diseases due to infection were not accepted 
and this discovery preceded by years of Koch's discovery of tubercle 
baci l lus . 
The origin of leprosy is shrouded in the mists of antiquity. 
Its ear l ier spread is also a matter of surmise. WHO has made several 
attempts to collect global data on the leprosy situation. The estimated 
number of cases in the world today is around 12 millions distr ibuted over 
several countries. This disease however, has been present in the Indian 
subcontinent for several centur ies . Information regarding i ts extent and 
distributions have been meagre until recent years . The 1931 census gave 
the number of leprosy cases as 1.5 million. Since then antileprosy work 
has been intensified specially in the post independence, periods after 
1948, more part icularly after the National Leprosy Control Programme which 
was launched by the Government of India in 1955. The estimated number 
of cases have consequently been rising in successive decennial population 
counts. The main factors responsible for progressive increase were; rapid 
increase in population, increased case findings and increased voluntary 
reporting due to community awareness. The approximate number of cases 
in the country is 4 million based on the 1981 census population of 683.9 
million. The lepromatous rate ranges between 10-25% in different areas 
and the deformity rate is roughly 20%. About 400 million people live in 
hyperendemic and moderately endemic areas and are exposed to the r i sk 
of leprosy. In the country 72 d i s t r i c t s have been identified hyperendemic 
for leprosy with a prevalence rate of about 10/1000. The magnitude of 
the problem is therefore, vast and consequent need to achieve the control 
over the disease gains a greater urgency in the context of attaining our 
social objective of health for all by 2000 AD. 
Leprosy i s normal ly a v e r y ch ron ic d i s e a s e . The s eve re forms 
tend to d e t e r i o r a t e with t i m e , and the most s e v e r e and contagious forms 
l a s t for l i f e , without much affecting t h e l i fe span . The l i fe expectancy 
of pa t ien ts in some cases i s sho r t ened by a few years s p e c i a l l y in the 
lepromatous forms. In more than one t h i r d of un t rea ted or advanced c a s e s , 
l e p r o s y r e s u l t s in d i s a b i l i t i e s which inc rease wi th t ime and become perma-
nent . These d i s a b i l i t i e s affect mainly the e x t r e m i t i e s and the face including 
the e y e , resu l t ing in se r ious impai rment of working capac i ty and d i s rup t ion 
of the social l i fe of the p a t i e n t , who becomes an outcas t in the s o c i e t y . 
The d i s a b i l i t i e s and de fo rmi t i e s of l e p r o s y pa t i en t s have in many 
cu l tu ra l s y s t e m s , r e s u l t e d in t h e bel ief which may even be h e l d today 
by hea l th w o r k e r s , t h a t the d i s e a s e has n e c e s s a r i l y incurab le consequences . 
The degree of social o s t r ac i sm re su l t i ng from t h i s a t t i t u d e makes the pa -
t i en t s t hemse lves convinced t h a t t h e i r exc lus ion from the community is 
j u s t i f i e d . A s imi la r feeling of gui l t may even be s h a r e d by the p a t i e n t ' s 
f ami l i e s . 
Leprosy af f l ic t ions go th rough p h a s e s . The grea te r p a r t of the 
populat ion having contact wi th p a t i e n t s wi th m u l t i b a c i l l a r y forms of l ep rosy 
may be in fec ted . The defense (Immune s t a t u s ) in most cases wil l l imit 
and a r r e s t the mul t ip l ica t ion of l e p r o s y b a c i l l i before s igns of the d i sease 
a p p e a r . In some i n d i v i d u a l s , t h e d i s e a s e wil l p r o g r e s s to c l in ica l forms 
of l e p r o s y . The e a r l i e s t r ecogn i sed form of the d i sease is inde terminate 
l e p r o s y . Th i s i s an e a r l y uns t ab l e form in which majori ty of the pa t i en t s 
wi l l control t h e infection leading to spontaneous heal ing without t rea tment 
(Lara and Nolasco, 1956). Some p a t i e n t s wi th inde te rmina te l e p r o s y wil l 
p r o g r e s s to more p e r s i s t i n g d i s e a s e wi th a spec t rum from p a u c i - b a c i l l a r y 
tube rcu lo id (TT-BT) l e p r o s y to m u l t i - b a c i l l a r y lepromatous (BL-LL) l e p r o s y . 
The l a s t form is the most infec t ious and has the longest incubat ion p e r i o d . 
An average pe r iod of tour y e a r s ranges from exposu re to the appearance 
ot c l in ica l s igns of the d i s e a s e . 
Sulphone t h e r a p y in l e p r o s y was s t a r t e d in 1941 and i t was b e -
l i eved that l ep rosy could be con t ro l l ed wi th the he lp ot t h i s d rug . The 
appearance of Dapsone (DDS) r e s i s t a n t l e p r o b y , and the need to continue 
DDS treatment tor l i t e long in l epromatous l ep roby pa t i en tb , has led to 
a f a i lu re in the control ot l ep ioby by DDS alone in most areab ot the world 
wi th l e p r o b y . Today on a WOT Id bcale l e p r o s y might be or. the incieabe 
(Lara & Nolasco, 1956). 
The screening programmes to detect cases of leprosy started 
long back in the leprosy endemic a reas . But the progress has been and 
st i l l is hampered by difficulties encountered in the diagnosis of early 
leprosy and leprosy in the incubation period. It is increasingly important 
that an early diagnosis of leprosy be made since antileprosy treatment 
can limit the spread of leprosy and it is much easier to treat leprosy 
in earl ier stages than in the advanced s ta te . Epidemiological studies of 
leprosy have been and s t i l l are difficult to car ry out for want of methods 
to identify human beings infected with leprosy bacil l i in the absence of 
full blown symptoms. The real problem has been to detect the early cases. 
Koch's delayed hypersens i t iv i ty (1890) test (tuberculin) has 
helped enormously in calculating the percentage of people infected with 
tuberculosis who later develop the disease. On the same pattern lepromin 
test was evolved by Mitsuda in 1919, but th is test has not provided any 
useful information excepting that it differentiates between tuberculoid and 
lepromatous form of the disease . Therefore, a very important tool in diag-
nosing leprosy becomes pract ical ly useless and other methods have to 
be looked upon. In the past several years other tests have been used 
with l i t t le success. Mention may be made of complement fixation test where 
the antigen or antibody may be detected through serological tests but 
this test in leprosy has not proved to be useful. Rubino test and antigen-
antibody detection in gels by Ouchterlony or Oudin methods have been 
used in the past with no success. During recent years several other tests 
have been devised and used with some success. These tests comprise of 
cross-immunoelectrophoresis, fluorescent antibody tes t , radioimmune assay 
and enzyme linked immunosorbent a s says . These tests have provided certain 
very useful information and may be used in detecting cases suffering from 
leprosy. 
Crossed Immunoelectrophoresis test has been developed and t r ied 
to a limited extent. Rojas Epinosa £t_ al_. (1976) using this technique demons-
trated the presence ot anti-mycobacterial antibodies in the sera of patients 
suffering trom lepromatous leprosy . The antigen was prepared from isolated 
Mycobacterium leprae . Harboe ej_ al_. (1977) using this test showed that 
lepromatous sera contain over twenty antibodies reacting with Mycobacteria. 
Harboe et_ al_. (1978) developed radio-immunoassay with the use 
of radiolabelled M. leprae antigen prepared from purified sonicated M. 
l ep rae . A method was developed by Buchanan for the early detection of 
systemic infection in armadillos through a sensit ive ELISA test which detect 
antibody to arabinomannan. This test appears to be a simpler one and 
is stated to be specific. 
Studies on enzymatic pattern and protein estimations have been 
carried out in isolated cases . These studies indicated that there is certainly 
an appearance of serum enzymatic changes in early phases of the disease. 
The protein values have also indicated gross abnormalities in different 
cases . But the changes in the level of enzymes or proteins have not been 
correlated among themselves. Since these changes are non-specific and 
may appear in several other diseases a positive correlation has to be 
established by using some specific parameters of study along with these 
non-specific ones. Serum immunoglobulin patterns have been studied in 
leprosy at t imes, but these specific changes have not been analysed in 
relation with other parameters. 
A readi ly available and chemically characterized leprosy specific 
antigen would be a valuable tool for diagnosis and toxonomic s tudies . The 
vaccine programme at IMMLEP has recently led to an unexpected break 
through in finding M. leprae specific antigen. The Wellcome Foundation 
in the course of removing large amount of bacteria from armadillo tissues 
for making t r ia l vaccine, produced l i t e r s of left over supernatants, contain-
ing soluble molecules from the sick animal t i s sues . This was reacted with 
serum from leprosy patients on the remote chance that it might contain 
surface molecules or antigens specific to M. leprae which would bind with 
patients ant ibodies. The solution contained the antigen, which was at a 
higher concentration than in the bacteria themselves. This indicated that 
it is actively secreted by the bacter ia . The antigen was identified as 
a simple universal glycolipid having three sugar molecules with a fatty 
component of M. leprae cell wal l . It has been synthesized at National 
Institute tor Medical Research, London and is presumed to work as an 
art if icial vaccine costing much less than the materials obtained from Arma-
di l los . Scientists at Seattle have modified the antigen and bound it to 
plastic, plates to conduct ELISA. When serum containing antileprosy antibody 
is added to antigen coated d i shes , antibodies are bound to the d ishes . 
A colour producing test for bound antibodies then reveals that sera contain-
ed anti-i;^. leprae ajitibodies. This test seems to be absolutely specific 
for leprosy antibodies, and will not react with blood from people with 
related mycobacterial infection. 
Despite the sensi t ivi ty and specificity attached to this antigen 
it would be difficult to procure i t since the source of M. leprae itself 
is limited and is constantly dying out due to mass treatment. Therefore, 
some alternatives have to be thought of. If some antigenically related 
atypical mycobacteria, which is capable of detecting the same or appro-
priate percentage of cases of leprosy like that of M. leprae glycolipid, 
is sorted out the problem of scarci ty of antigenic avai labi l i ty may be 
abbrevia ted. 
This laboratory has been working from the past several years 
on an antigenically related strain of Mycobacterium/designated M. habana. 
Its possibi l i ty to detect anti leprosy antibodies in humans through cell 
sonication or in particulate state may provide some useful information regard-
ing the diagnosis of leprosy. 
This study has been undertaken for : -
1. Detection of U. leprae specific antibodies through ELISA 
test using part iculate M. leprae antigen as control. 
2. Comparison of M. habana antigen through ELISA test 
to detect M. leprae antibodies in the sera samples 
of leprosy pat ients . 
3. Patterns of Immunoglobulin in the sera of leprosy pa-
t ients . 
4. Serum enzyme profile during various phases of leprosy 
along with contacts and healthy individuals . 
5. Total serum protein and albumin/globulin estimations 
in the sera samples ot various grades ol leprosy and 
its comparison with tuberculosis patient sera . 
ENZYME LINKED IMMUNOSORBENT ASSAY ELISA 
REVIEW OF LITERATURE 
ENZYMES LINKED IMMUNOSORBENT ASSAY 
Serological methods are playing an increasingly important role 
in the diagnosis and epidemiological assessment of infectious diseases. 
Simple, less expensive serological methods for large scale field study 
are needed urgently for ear ly diagnosis of leprosy. The enzyme immuno-
assays are very promising tes ts for application in a wide variety of condi-
tions. The method, if standardized is simple, cheap and easy to carry 
out on large scale and can be easi ly adopted for field conditions. Enzymes 
had been used as markers in immunological studies since 1960 but they 
were first used in solid phase assay for quantitative determinations of 
protein by Engvall and Perlmann (1971 and 1972) and Van Weeman and Schu-
urs (1971). 
These two groups almost simultaneously but independently, a r r ived 
at the conclusion that if an antigen or antibody was conjugated with a 
suitable enzyme without loss of immunological or enzymic reac t iv i ty , th is 
conjugate could be used successfully in the diagnosis of infectious diseases 
125 in a manner similar to I conjugate. The difference being the marker, 
that is the radioimmuno assays measures the radio isotope by emitted 
radiation and enzyme linked immunosorbant assay (ELISA) quantitates the 
enzyme biochemically by i t s action on the substrate in the presence of 
a chromogen. Theory, techniques and application of this technique is des-
cribed by World Health Organization (1976, 1977), Voller (1978) and Voller 
et_ al^. (1978a, b ) . 
For the f irs t time the ELISA technique was applied in Malaria 
by Voller et_ a\_. (1974a). The antigen was immobilised on a suitable solid 
phase (usually polystyrene) and allowed to interact with test serum thought 
to contain specific antibody. The antigen-antibody conjugate was then incu-
bated with enzyme conjugated second antibody. After washing off the un-
reacted enzyme conjugate, the bound enzyme act ivi ty was retained on solid 
phase, which was detected biochemically. 
This test and i t s modifications were applied successfully by 
several workers in the seroepidemiological studies ot several other diseases. 
A number of laboratories have developed immuneassays for leprosy. 
These ^ssays include: Fluorescent leprosy antibody-absorption test (FLA-ABS) 
developed by Abe e^ al_. (1980), the radioimmunoassay (RIA) with antigen 
7 developed by Harboe et^ aj_. (1978) and Enzyme Linked Immunosorbenr 
Assay (ELISA) with arabinomannanas developed by Miller e£ a^. (1983). 
Difterent physical states of the antigens have been used. Some workers 
have tr ied extracts of mycobacteria as the antigen. Douglas e^ a^. (1984) 
have advocated the use of whole mycobacterial cell as the antigen. The 
choice was based on the premise that cell surface antigens are easily 
recognized by the immune system of the host. It is also possible that 
antigens which have been extracted from cells may either have altered 
determinants or have been denatured. Another possibi l i ty may be that 
extracted antigens may not be presented in immunoassay in the same way 
as they are presented on the ce l l s . In addition to the application of whole 
cells to the ELISA they had chosen not to absorb the sera prior to testing 
but to establish a back ground for natural antibodies level , to common 
determinants of mycobacteria. They had examined several related organisms 
in the Corynebacteria/mycobacteria groups including M. leprae to determine 
the best candidate for a whole cell antigen. They used the whole cells 
of M. smegmatis, M. vaccae, M. scrofulaceum, M. leprae , C. diphtheriae 
and C. xerosis and compared thei r effect against leprosy pat ient ' s sera. 
They found that M. smegmatis was the most reactive against lepromatous 
sera with OD , readings 1.5 times and five times higher than the others . 
In addit ion, when M, smegmatis was coated to microtitre plates with a 
volatile ammonium acetate/carbonate buffer and air dr ied , the antigen coat-
ing was found to be three times more reactive than antigen coated with 
nonvolatile buffer. Autoclaving of M. smegmatis increased the react ivi ty 
with LL sera 1.4 to 2.3 fold. M. leprae was found to be 4-10 times more 
reactive than autoclaved M. smegmatis. Autoclaving of M. leprae did not 
increase i ts reac t iv i ty . Both antihuman IgG and antihuman IgA, IgM and 
IgG combined conjugates were found to be equally effective in detecting 
high levels of antibodies in patients with multibacillary disease. 
Miller et_ aj_. (1983) describing the ELISA technique reported 
that no antigen assay has been developed that can detect an antibody res -
ponse in 100% ot leprosy pat ients . Misake e£ al_. (1977) and Ellner and 
Daniel (1979) reported two ot the complex polysaccharides found in 
mycobacteria an arabinogalactan (AG) and an arabinomannan (AM) which 
were immunologically ac t ive . The arabinogalactan is a major structural 
component of the cell wall and AM appears to be cell wall associated. 
Despite minor biochemical differences in polysaccharides of different spe-
cies of mycobacteria, extensive immunologic cross react ivi ty is present. 
Miller et^ &]_. (1983) purified an antigen composed predominantly of arabi-
nomanan from M. smegroatis and used it in ELISA to detect antimycobacterial 
antibodies in human sera. As high as 95% of the LL cases had highest 
t i t re values than ei ther TB or TT leprosy cases . 
Douglas and Worth (1984), reported that M. leprae specific antigen 
has not been available t i l l recent ly . Humoral antibody studies have been 
limited to antigen which has some common components shared by other 
mycobacteria. They used M. smegmatis as the antigen and evaluated that 
increased antibody t i t r e in ELISA in the sera of preclinical cases of lep-
rosy predicts the occurrence of the disease ear l ier than the clinical app-
earance. 
Species specific antigens have long been sought in Mycobacterium 
leprae to be used for subclinical diagnosis of leprosy and to differentiate 
it from tuberculosis and other infections caused by a plethora of environ-
mental mycobacteria. Caldwell et_ a\_. (1979) and Gloss et_ al_. (1979) have 
used concentrated protein antigens for the reasons that Mycobacterium, 
like other gram positive and gram negative bacteria may have characteris t ic 
cell wall proteins. Goren and Brennan (1979) reported myriads of biological 
act ivi t ies of the cell wall l ip ids and found evidences of species specific 
antigenecity and came out with the evidence of a phenolic glycolipid in 
M. leprae , with an unique sugar arrangement, which may be an important 
tool for leprosy research. 
Harboe (1984) has suggested that if antibodies ar ise after infection 
and before the development of clinical symptoms ot the disease, it may 
be possible to study the epidemiology of leprosy infection. Several investi-
gators (Yoder et_ al_. , 1979; Harboe, 1981; Brett e^ al_. , 1983; Harboe, 
1984) have shown that antibody concentration is higher in multibacillary 
leprosy, than in the paucibacillar y type which may co-relate antigenic 
load to antibody t i t r e s . This relat ionship might be important, lor the 
early diagnosis and control of the individuals responsible lor the trans-
mission ot the disease in the community. 
The levels of humoral antibodies in leprosy patients have been 
reported to reflect different clinical forms of the disease (Myrvang e^ 
a l . , 1974; Touw £t_ aj.-« 1982) and to change the alteration in antigen load 
during chemotherapy (Rees et_ aU , 1965; Touw et_ al_. , 1982). The varying 
amount of antigenic load and the level of antibodies can be detected to 
monitor the disease through chemotherapy. 
Recently the discovery of a M. leprae - specific phenolic glyco-
lipid (PGL-1), which could be extracted in large amounts from M. leprae 
infected armadillo t issues has opened up new perspect ives in the field 
of leprosy serology (Brennan & Barrow, 1980; Brett £t_ al_. , 1983; Draper 
et_ al_. , 1983; Young and Buchanan, 1983; Cho et_ aj_. , 1984). This phenolic 
glycolipid with a structure related to that of mycoside-A of Mycobacterium 
kansasii (Goren 1972) was found in M. leprae preparations by Draper (1980) 
and i ts structure was elucidated by Hunter and Brennan (1981). The unique 
t r isaccharide component of the glycolipid (2,3-diorthomethyl rhamnose, 
3-0-methyl rhamnose and 3,6-di-O-methylglucose) suggests that it may cons-
titute a species specific antigen, but they were unable to demonstrate 
i ts serological ac t iv i ty using the purified l ipid (Hunter and Brennan, 1981). 
Payne et_ aj_. (1982), however, showed that the l ipid is active in immuno-
diffusion experiments when it is incorporated into liposomes, and other 
workers indicated the possible use of the native phenolic glycolipid in 
an ELISA system (Hunter et_ al_. , 1982; Brett et^  aj_-• 1983). 
Young and Buchanan (1983), have reported that they have deve-
loped an ELISA system in which the deacylated form of the phenolic glyco-
l ipid is used. The fact, that the l ip id is found in large amounts in skin 
lesions of leprosy patients (Young, 1981) and in tissues of experimentally 
intected nine banded armadi l los . Hunter & Brennan (1981) suggested that 
it may play an important role during leprosy infection and also that it 
will be available in sufficient quantities for use in large scale serological 
screening. 
Young and Buchanan (1983) have reported that the advantage of 
using the deacylated glycolipid was seen by comparing i ts performance 
to that ot native l ip id in the ELISA test . At a concentration of 4 ug/ml, 
the A A observed with lepromatous leprosy serum was 1,2 with the de-
acylated glycolipid, and 0.06 with the native glycolipid. Even at coating 
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concentrations as high as 32 ug/tnl, the ^ A ELISA readings did not 
exceeds beyond 0.24 with the native glycolipid, in contrast the deacylated 
molecule at a coating concentration of 1 iUg/tnl produced a / W . Q ^ of 0.34. 
The poor performance character is t ics of purified phenolic glycolipid in 
the ELISA may result from antigenic t r isacchar ide moieties being masked 
by excess l ip id . Even with procedure recommended by other workers (coat-
ing with hexane. Hunter e^ aJ_. , 1982) or in the presence of sodium deoxy-
cholate (Brett et_ a\_. , 1983). The specific act ivi ty seem to have been 
masked. Young & Buchanan (1983) have found that only serum from patients 
strongly positive for lepromatous leprosy had antibody levels detectable 
by ELISA when the native glycolipid was used as antigen. This is with 
marked contrast to the resul ts with the deacylated molecule as antigen 
(Young and Buchanan, 1983). 
Incubation of serum with the deacylated glycolipid (1 pg/ml) 
in aqueous suspension for 1 hr at 37°C before they were added to ELISA 
plates resulted in inhibition of 70 percent in the phenolic glycolipid t i t re 
with the M. leprae l ipid and an inhibition of only 10 percent with the 
M. kansasii l ip id (Young & Buchanan, 1983). 
Young & Buchanan (1983) have reported that in ELISA using deacy-
lated phenolic glycolipid is potentially a highly specific assay for detec-
tion of humoral response to leprosy infection, and for the f irs t time repre-
sent a direct method for studying such a response without complication 
due to previous exposure to environmental mycobacteria or BCG vaccination. 
Antibodies of the IgM class directed against PGL-1, a species-
specific, cell wall associated antigen of M. leprae (Brennan and Barrow, 
1980) and antibodies of both the IgM and the IgG classes directed against 
whole M. leprae were measured by ELISA (Bach et_ al_. , 1986) method in 
sera from lepromatous and tuberculoid patients and normal subjects. Normal 
subjects who had no known exposure to M. leprae displayed very low 
IgM binding ac t iv i ty to PGL-1, in accordance with the previously reported 
exquisite specificity of this antigen with regard to M. leprae (Brett £t^  
a l . , 1983; Cho £^ aj_. , 1983; Young and Buchanan, 1983), conversely they 
showed significant antibody act iv i ty to whole M. leprae especially of the 
IgM class , which might result from a previous exposure to cross reacting 
mycobacteria. According to Bach £]_£!_. (1°86) untreated lepromatous patients 
exhibited a high level ot anti M. leprae antibodies in all three enzryme 
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linked immunoassays i . e . anti PGL-1 antibody, anti M. leprae sonicate 
antibody and anti whole cell M. leprae antibody. 
According to Bach et_ aj_. (1986) a rapid fall of IgM antibodies 
directed either to PGL-1 or to whole M. leprae was observed within a 
year after onset of treatment, but noticeable individual variations were 
seen in the ELISA tes t . On the other hand, IgG antibodies to whole M. 
leprae declined more slowly, although antibody levels as measured by 
all three assays were found to correlate to the Bacteriological Index (BI) 
and to each other ; the only significant correlation remaining when this 
effect of bacil lary load was eliminated a week correlation between anti-PGL-
1 and anti-whole M. leprae IgM antibody leve ls . These data suggested 
that as expected, IgM antibodies against whole M. leprae include some 
IgM antibodies directed to PGL-1. 
In addition to this there appears to be other antibodies directed 
against unrelated antigens in the Immunoassays probably polysaccharides 
or l i p id s , which el ici t the production of antibodies of the IgM class more 
than proteins (Perlmutter et_ a_l_. , 1978). Conversly, anti-whole M. leprae 
antibodies of the IgG class would recognize different types of antigens, 
including proteins . The data represented by Bach et_ aj_. (1986) indicate 
that the follow up of anti PGL-1 IgM antibody levels during the first 
year of therapy, may be used as a rapid and sensitive tool for evaluating 
treatment efficacy, at least in non reactional pat ients . A large percentage 
of lepromatous patients treated for more than four years st i l l presented 
significant antibody act ivi ty against PGL-1 or whole M. leprae (of the 
IgG class only in the lat ter case) in the ELISA. In this group of patients 
whose BI ranged from 0 to 1, anti-PGL-1 antibodies but not anti-whole 
M. leprae IgG antibodies were found to be closely correlated to the BI, 
suggesting that anti-PGL-1 antibodies probably represent a better indication 
of persisting J^. leprae infection than IgG antibodies against the whole 
baci l lus . On the other hand, IgG antiwhole M. leprae antibodies could 
represent a rel iable tool tor re t rospect ive detection of M. leprae intection 
in epidemiologic s tudies , their data are in close agreement with those 
ot Touw £t_ a l^. (1982) who found a rapid decrease ot IgM antibodies to 
whole M. leprae within a year, with persisting high t i t res of IgG antibodies 
but contradict those ol Melsom et^ aj_. (1982) who observed in 10 year 
created lepromatous patients a persisting antibody production of the, IgM 
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class but not of the IgG class in ELISA system. It must be noted that 
Melsom e^ aj_, (1982) used a soluble M. leprae sonicate as antigen whereas 
Touw et_ al_. (1982) and Bach et^  al_. (1986) used whole M. leprae suspen-
sions l ikely to contain a different proportions of cell wall associated ver-
sus cytoplasmic antigens. 
Tuberculoid patients display an antibody pattern quite similar 
to that of long term treated lepromatous pat ients , that is a significant 
production of IgM anti PGL-1 antibodies and of IgG antiwhole M. leprae 
antibodies (but at a lower level and with a lower frequency than untreated 
lepromatous patients) without detectable IgM antibodies against whole M. 
leprae (Bach e^ al_. , 1986). 
As a whole, the detection of anti-M. leprae antibodies through 
ELISA using different antigens is possible but the picture seems to be 
confusing and needs elucidation. 
MATERIALS AND METHODS 
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CHEMICALS 
Various chemicals l ike Cardiolipin, leccithin, enzyme conjugate-
Antihuman IgG (Heavy and light chains) labelled with horseradish peroxi-
dase, enzyme subst ra te , orthophenylene diamine dihydrochloride (OPD), 
Bovine serum albumin (BSA) and Fetal calf serum were purchased from 
Sigma Chemicals, U.S.A. 
Glutaraldehyde was purchased from SISCO research laboratory 
Bombay for the fixation of antigen into ELISA pla tes . 
Disodium hydrogen phosphate (Na HPO.), Potassium dihydrogen 
orthophosphate (KH PO.) , Sodium chloride (NaCl), Sodium carbonate (Na^-
00 ) and Citric acid were purchased from BDH Laboratory Chemicals group, 
U.K. 
Disposable flat bottom, polystyrene microtitre plates (Cooke, 
microtitre N^. AR) with ninty six wells were purchased from Dynatech 
Laboratories, Singapore. 
PREPARATION OF MEDIA 
To prepare Sauton's media following ingredients of standard firms 
of (AR/GR grade) were used according to the specification laid down by 
the International Union against tuberculosis (Long ER 1958). 
(a) L-Asparagin Monohydrate 
(b) Citric Acid 
(c) Dipotassium hydrogen phosphate 
(d) Magnesium sulphate 
(e) Ferric Ammonium ci t ra te 
(f) Glycerol 
(g) Double dis t i l led water 
4.00 gms 
2.00 gms 
0.5 gms 
0.5 gms 
0.05 gms 
35.0 ml 
1000.0 ml 
All the ingredients were taken in a s te r i l ized flask, s t i r red 
well to dissolve and pH was adjusted to 7.2 by adding 40% sodium hydro-
xide (NaOH) solution drop by drop. This media was distr ibuted in s te r i -
lized Roux bottles in an amount of 150 ml to each bot t le . All these Roux 
bottles were autoclaved at 15 lbs pressure for 20 minutes and used tor 
cultivation ot mycobacteria. 
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A. PREPARATION OF ANTIGENS FOR COATING OF WELLS IN ELISA 
(a) Armadillo derived M. l eprae , was provided by the kind courtesy 
of Prof. Nooruddin, WHO, Geneva which was autoclaved at 15 lbs steam 
pressure for30 minutes and suspended in PBS (7 .2 ) . Bacilli were disclumped 
through a microtip with minimal power of cell disruption (185 Branson 
Sonic Power Co. Danburg Connecticut, U.S.A.) for 15 minutes to obtain 
a homogenous suspension. For preservation 0.1% sodium azide was added 
and suspension stored at 4''C until use. 
(b) Live bacill i of M. habana strain were harvested from liquid 
Sauton's media after a fortnight culture, washed three times with PBS 
(pH 7.2) and divided equally in two portions. 
(c) One portion was kil led by y- i r radia t ion (300 K rads . through 
a CO source) disclumped and suspended as above. 0.1% sodium azide 
was added as preserva t ive and stored at 4°C until use, 
(d) Second portion was subdivided equally into two par t s : 
(i) 1st part was suspended and diluted in PBS after disclumping 
the bac i l l i . 
(ii) The remaining part was sonicated for 240 min at interrupted inter-
vals . Every time a smear was made, stained and examined for the presence 
of intact bac i l l i . The sonication was continued t i l l no bacill i were detec-
table microscopically. The sonicated mass was centrifuged at 5000 rpm 
for 15 minutes and the supernatant was separated. Protein estimation of 
the supernatant was done by Lowry's (1951) method. 
B. PREPARATION OF ANTIGENS FOR AGGLUTININ ABSORPTION TEST 
M. tuberculosis (H Ra), M. vaccae and M. bovis (BCG) were 
harvested separately from Sauton's media. The growth was washed thrice 
and resuspended in PBS (7 .2 ) . Disclumping of the bacil l i was done with 
light sonication. The yield comprised ot particulate antigen ot each myco-
bacterial s train which was stored at 4°C after addition ot 0.1% sodium 
azide. 
C. COLLECTION OF SERA SAMPLES 
"Five ml ot venous blood was drawn asept ical ly from each patient 
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having va r ious g r a d e s of l e p r o s y along with t h e contacts and s ib l ings 
of lepromatous p a t i e n t s th rough t h e cour t e sy of Mission Leprosy Hospi ta l , 
Ba rabank i . Blood samples from t u b e r c u l o s i s pa t i en t s were co l lec ted through 
the cour te sy of Dr. V .B . Singh, Senior Ches t P h y s i c i a n , Balrampur Hospi ta l , 
Lucknow, These samples w e r e Incubated a t 37°C for 2 h r and la te r on 
at 4''C ove rn igh t to ob ta in maximum serum y i e l d . Cases having h i s t o ry 
of d i a b e t e s - m e l l i t u s , in fec t ive h e p a t i t i s , a lcohol ic h e p a t i t i s and malaria 
were not inc luded in t h i s s t u d y . 
D. ABSORPTION OF SERUM FOR MONOSPECIFICITY 
Diluent 'A' 
C a r d i o l i p i n - l e c i t h i n (0.4% in abso lu te a l coho l ) was mixed r a p i d l y 
with PBS (7 .2 ) in a p r o p o r t i o n of 1 and 19. This was r e f e r r e d as Diluent 
' A ' . 
Diluent 'B' 
Nine volumes of Diluent ' A ' were mixed with one volume of 1% Bovine 
serum albumin (BSA-fraction V) solut ion (w /v in PBS pH 7.2) and mixture 
was named as Diluent ' B ' wh ich was used for the d i lu t ion of abso rbed 
serum. 
E. ABSORPTION AND DILUTION OF TEST SERUM 
A minimal q u a n t i t y of 0.05 ml of serum was mixed wi th equal 
volume of H Ra, BCG and M. vaccae suspens ion and d i lu ted to a final 
concentrat ion of 1:10 wi th a d d i t i o n of 0.35 ml d i luent 'A ' (0.05 ml serum 
to a final volume of 0.50 m l ) . The mixture was incuba ted a t 37°C for 
30 min and cent r i fuged at 2000 rpm (500 x g) for 15 min to obta in the 
maximum pe l l e t of t h e m y c o b a c t e r i a . The superna tan t was recentr i fuged 
at 10,000 rpm (5500 x g) for 5 min (M-15, Sakuma Seisakusho L t d . , Ohta-Ku 
T o k y o ) . The c l ea r supe rna tan t was fu r the r d i lu t ed wi th Diluent ' B ' to 
p r e p a r e d i lu t ions i . e . 1:100 for t h e t e s t p r o p e r . 
F. ENZYME LINKED IMMUNOSORBENT ASSAY 
a) Carrier surface 
Disposable f la t bo t tom, p o l y s t y r e n e mic ro t i t r e p l a t e s (Cooke, 
e N AR, Dynatech L a b o r a t o r i e s , 
used as the c a r r i e r sur face tor the ant igen. 
Micro t i t re a b o r a t o r i e s , Singapore) wi th 96 wel l s were 
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b) Reference sera 
The positive reference (+ve ref) serum contained serum infected 
with Leprosy, while negative reference (-ve ref) serum was a pool from 
apparently healthy human beings. 
c) Enzyme conjugate and substrate 
Enzyme conjugate antihuman IgG (Heavy and Light chains) labelled 
with horse raddish peroxidase (HRP) and Enzyme substrate orthophenylene-
diamine dihydrochloride (OPD) was obtained from Sigma Chemicals, U.S.A. 
for measurement of the Peroxidase ac t iv i ty . 
G. STANDARDISATION OF THE OPTIMAL DILUTION OF ANTIGEN, SERUM 
AND CONJUGATE 
For the standardisation of the optimal dilution of antigen, serum 
and conjugate, posit ive reference pooled LL sera and negative reference 
pooled Normal Sera were used. 
A series of M. leprae part iculate antigen dilutions ranging from 
0.125 C D . to 2.00 C D . at 420 nm were used for sensitizing the microtitre 
plate. For M. habana sonicated antigen dilutions from 5 ug/ml to 100 pg/ml 
were used to sensitize the microtitre p la te . 
These dilutions were tested with a ser ies of serum dilutions 
ranging from 1:50 to 1:800 of +ve reference as well as -ve reference sera 
samples. 
The optimum antigen dilution was 0.500 C D . at 420 nm and opti-
mum serum dilution of 1:100 dilution with autoclaved U. leprae (particulate) 
antigen giving high reading with positive serum dilution and low reading 
with negative serum dilution (having highest P/N ratio i . e . 4.83). M. 
habana sonicated antigens, optimum dilution was 20 ug/ml and optimum 
serum dilution was 1:100 (highest P/N ratio i . e . 3 .06). 
Atter determination of optimum antigen and serum dilutions, opt i-
mal conjugate dilution was sought out by chequer board t i trat ion. 
1:1000 conjugate dilution was found optimum tor both-autoclaved 
M. leprae (part iculate) antigen (P/N = 3,10) as well as tor M. habana 
sonicated antigen (P/N = 2.55) . 
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H. COATING BUFFER FOR SONICATED ANTIGEN (0.06M, pH 9 .6) 
(a) Solution (A) l.OM NaHCO^ . . . 45.3 ml 
(8.400 gm/100 ml D i s t i l l e d w a t e r ) 
Solution (B) l.OM Na CO . . . 18.2 ml 
(10.600 gm/100 ml Di s t i l l ed wa te r ) 
Now make i t upto one l i t r e with t r i p l e g lass d i s t i l l e d water 
to get the mola r i ty 0 .06 . 
(b) Phospha t e -bu f f e r ed sa l ine (0 .15 M, pH 7.2) 
0.15 M Na^HPO, anhydrous . . . 380 ml 
2 4 
0.15 M KH^PO^ . . . 120 ml 
2 4 
0.15 M NaCl . . . 1000 ml 
(c) C i t r a t e buffer pH (5 .0 ) 
0.1 M c i t r i c a c i d . . . 24.3 ml 
(21.014 gm in lOOOml Di s t i l l ed wate r ) 
0.2 M Na,HPO^ . . . 25 .7 ml 
2 4 
(28.392 gm in 1000 ml D i s t i l l ed wate r ) 
Mix wel l and make 100 ml by adding 50 ml of T r i p l e g lass d i s -
t i l l ed w a t e r . 
(d) Subs t r a t e r eac t ion mix ture 
C i t r a t e buffer . . . 50 ml 
Or thopheny lene diamine 
D i h y d r o c h l o r i d e (OPD) . . . 20 mg 
H O (30% aqueous solu t ion) . . . 20jUlit. 
5% t e t a l calf s e rum, 1% g l u t a r a l d e h y d e , 2.5N and 8NH SO solut ions 
were a l so p r e p a r e d for use in ELISA. 
I . PROCEDURE FOR ELISA 
a) Coating of sonicated antigen 
Hundred jul ot son ica ted ant igen d i lu ted in coating buffer ( sod . c a r b o -
na t e -b i ca rbona t e buffer pH 9.6) was d i spensed in each well of t lac bottom 
mic ro t i t r e p l a t e s , incuba ted at 37°C tor 2 hr and then left at 4°C ove r -
n igh t . Alter ove rn igh t incuba t ion , the p l a t e was washed t h r i c e with phos -
phate buffered sa l ine (PBS, pH 7.2) and then incuba ted for 2 hr at 37°C 
with lOO ul bovine serum albumin (51 w / v ) in PBS per we l l . The bovine 
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serum albumin was then r e p l a c e d wi th 100 til serum samples d i lu ted in 
PBS containing fetal calf serum (5% by volume) and p l a t e s were incubated 
for 2 h r at 37°C. The p l a t e s were washed four t imes wi th PBS. Pe rox idase 
l a b e l l e d goat ant ihuman IgG was a d d e d a t a d i l u t i on of 1:1000 in PBS 
along with fe ta l calf serum (1% by vo lume) . F u r t h e r incubat ion was for 
1 hr at ST'C and p l a t e s were w a s h e d four t imes with PBS. 0.4 mg/ml 
0 -pheny lene diamine d i h y d r o c h l o r i d e in c i t r a t e buffer (pH 5.0) containing 
0.006% of final volume of H 0_ was a d d e d in 100 p i / w e l l q u a n t i t y . 
Reaction was s t o p p e d by a d d i t i o n of 8N H SO. (25 ju l /we l l ) . After 
incubat ion for 20 min at room t e m p e r a t u r e , abso rbance was o b s e r v e d through 
an ELISA Reader a t 492 nm. 
b) Coating of particulate antigen 
Twencyfive ul of p a r t i c u l a t e an t igen suspens ions were d i s t r i b u t e d into 
f lat bottom m i c r o t i t r e p l a t e s , and a l lowed to d r y ove rn igh t a t 2T'C. The 
b a c i l l i were t hen f ixed wi th g l u t a r a l d e h y d e (1% in PBS for 15 min a t 
room t e m p e r a t u r e . The p l a t e s were t hen washed wi th PBS (7 .2 ) and incuba-
ted wi th 200 pi (5% w / v ) PBS-BSA for 1 h r a t STC. Sera d i lu t ed to 1:100 
in (1% PBS-BSA) were a d d e d to p l a t e s and k e p t for 1 h r a t 3T'C. Plate 
then washed and incubated ove rn igh t a t 4°C in d a r k wi th Pe rox ida se l a b e -
l led antihuman IgG d i lu ted to 1:1000 in (1% PBS-BSA). 
After r ins ing t h e p l a t e s wi th PBS, t h e s e w e r e t hen a l lowed to 
r eac t wi th an OPD solut ion (100 ul of solut ion of 0 .4 mg/ml OPD in c i t r a t e 
buffer) and 0.013% H-O, of f inal volume incuba ted at 37°C for half an 
hour and reac t ion s t o p p e d by add ing 50 ul of 2 .5 N H SO . OD was read 
at 492 nm in automatic ELISA Reade r . 
RESULTS 
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The ELISA test was performed using two different kinds of anti-
gens, namely M. leprae and M. habana. The physical state of the antigens 
were primarily changed to study the variation in detecting the percentage 
of positive cases with each antigen. The serum collected from leprosy 
patients and thei r contacts was used as a source of I^. leprae antibodies 
either as such or after absorption with other antigens, to eliminate the 
groups specific and non-specific ant ibodies . Normally, leprosy patients 
serum was absorbed with M. tuberculosis H Ra, M. vaccae, BCG (Phipps) , 
cordiolipin and leci thin. U. habana antigen was used on the prelude that 
it has given protection against M. leprae , challenges in the foot pad of 
mouse and has generated several of the cell mediated immune responses 
resembling M. leprae antigenically. 
A. M. leprae (PARTICULATE ANTIGEN) STANDARDIZATION OF OPTIMAL 
DILUTION OF ANTIGEN AND SERUM 
M. leprae part iculate antigen was ser ia l ly diluted from 2.00 CD 
to 0.125 CD at 420 nm in PBS (pH 7.2) and used for sensitizing the Cooks 
microtitre p la tes . Each dilution of antigen was tested with all the dilution 
of (1:50 to l:800)of reference ( + )ve and (-)ve serum, using 1:1000 diluted 
HRP labelled antihuman IgG. 
The antigen and serum di lut ions, at which the difference between 
the extinction values {E _) of Ref (+)ve and Ref {-)ve serum i . e . P/N 
ratio was highest , were considered as optimal antigen and serum dilutions. 
A 4.83 fold difference was observed between the (E. ) value of Ref 
{+)ve and Ref (-)ve , serum at the antigen dilution of 0.50 CD at 420 
nm and serum dilution of 1:100 (Table 1). 
STANDARDISATION OF OPTIMAL CONJUGATE DILUTION 
The optimal conjugate dilution to be used in ELISA test was deter-
mined by the chequer board t i t ra t ion using the same Ref ( + )ve and Ref 
(-)ve sera . Results of this t i t ra t ion are presented in the Table 2 which 
indicated that the 1:1000 dilution of conjugate was optimal for obtaining 
a clear distinction between the Ref ( + )ve serum (CD = 0.59) and Ret(-) 
ve serum (CD = 0.19). 
At this dilution of conjugate difference between the OD of Ret 
{+)ve ^and Ref (-)ve serum samples was found 3.10 fold higher and this 
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was h ighes t compared to the va lues ob ta ined with o the r dilutions of the 
conjugate. 
ELISA REACTIVITY OF., LEPROSY PATIENTS AND CONTROL SUBJECTS SERUM 
USING M. leprae AUTOCLAVED PARTICULATE ANTIGEN 
Serum samples from d i f fe ren t groups of l e p r o s y spectrum, i . e . , 
from TT to LL and con t ro l s were ana lysed for the detect ion of ant ibody, 
using ELISA sys tem and r e s u l t s a r e p r e s e n t e d in Table ( 3 ) . 
For t h e normal h e a l t h y sub jec t s mean E. _ value of 0.181 with 
a s t anda rd dev ia t ion of 0.023 was ob t a ined . Cut off points for the specific 
diagnosis of l e p r o s y could be any of the t h r e e confidence l imits determined 
from E values of the normal h e a l t h y s u b j e c t s . 
Thus , at mean +SD (66% confidence l imi t ) 7 out of 20 (35%), nor-
mal hea l thy s u b j e c t s , 9 out of 20 (45%), TT cases and 100% of a l l the 
20 sera samples from each of BT, BB, BL and LL s p e c t r a of leprosy were 
found to have d e t e c t a b l e l imi t of l e p r o s y a n t i b o d y . 
At mean +2SD (95% confidence l i m i t ) , 15% and 35% of detection 
l imi t was r e c o r d e d for normal h e a l t h y subjec t s and TT cases respec t ive ly 
whi le 100% de tec t ab le l imi t was r e c o r d e d from BT to LL s i d e . 
At mean +3SD (99% confidence l i m i t ) , the h igher limit of an t i -
bod ies which were de t ec t ed in 100% cases were of BT, BB, BL and LL 
t y p e wh i l e t h e normal s u b j e c t s and TT cases dep i c t ed the observable 
l imit as n i l , and 25% r e s p e c t i v e l y . 
At a l l t he 3 cut off po in ts (66%, 95%, 99% confidence l imi t s ) 
each grade of l e p r o s y c a s e s e x c e p t TT were p o s i t i v e with E values 
of 0.355 for BT, 0.436 for BB, 0.615 for BL and 0.702 for LL r e s p e c t i v e l y , 
whi le in TT cases (E . = 0.204) 45% were p o s i t i v e at Mean + SD, 35% 
pos i t i ve at Mean + 2SD and only 25% p o s i t i v e at Mean + 3SD. 
ELISA USING M. habana YlRREDIATED (PARTICULATE) ANTIGEN WITH LEPROSY 
INFECTED SERUM (ABSORBED) 
Serum samples co l l e c t ed from different forms of leprosy spectrum 
i n i t i a l l y p rocessed unabsorbed were now abso rbed with various antigens 
in agglutinin a b s o r p t i o n t e s t to e l imina te group spec i f ic and non-specific 
a n t i b o d i e s . The ant igen remained the same ^ i r r a d i a t e d U. habana for o b -
se rva t ion ol v a r i a b i l i t y in de tec t ion pe rcen tage . Ca rd io l i p in , l e c i t h i n . 
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M. tube rcu los i s H Ra ( t u b e r c l e b a c i l l i ) , BCG and M, vaccae ant igens 
were used for a b s o r p t i o n . The r e s u l t s a r e summarized in Table ( 4 ) , 
A mean £ .„_ value of 0.114 with a s t a n d a r d dev ia t ion of 0.037 492 
was ob ta ined for normal h e a l t h y s u b j e c t s . Cut off po in ts for the spec i f ic 
d iagnosis of l e p r o s y remained t h e same t h r e e confidence l imi t s de termined 
from E.„_ va lues of the normal h e a l t h y s u b j e c t s . 492 
At mean + SD ( E . ^ - = 0,151) one out of f ive (20%), normal h e a l t h y 
persons (E = 0 .114 ) , 2 out of f ive (401) in TT c a s e s , 4 out of f ive 
(80%) in BT cases and 100% of r e s t of the t h r e e forms i . e . BE, BL and 
LL were found to have d e t e c t a b l e l imi t of l e p r o s y a n t i b o d y . 
While in the ca se of t u b e r c u l o s i s 3 out of f ive (60%) were having 
h igher l e v e l s of d e t e c t a b l e t u b e r c u l o s i s an t ibody af ter a b s o r p t i o n than 
the c o n t r o l s . 
At mean + 2SD (95% confidence l imi t ) t he o b s e r v a t i o n l imi t was 
nil in normal s u b j e c t s , one out of f ive (20%) and 2 out of f ive (40%) in 
t h e case of TT & BT serum r e s p e c t i v e l y . 
whi le in BB, BL & LL cases t h e detect ion l imi t was 100%, whereas 
none of the TB cases were d e t e c t a b l e at t h i s cut off poin ts af ter a b s o r p -
t ion of serum. 
At mean + 3SD (99% confidence l i m i t ) , i t was found to be nil 
in the case of normal s u b j e c t s , TT as well as in TB cases but c o n t r a r y 
to t h i s one out of f ive (20%) in BT, 4 out of 5 (80%) in BB and (100%) 
were d e t e c t a b l e in both BL and LL c a s e s . 
Thus at a l l t h e t h r e e cut off poin ts (66%, 95% and 99% confi-
dence l imi t s ) BL and LL c a s e s had h ighe r l eve l s of l e p r o s y an t ibody 
t i t r e , wh i l e in normal s u b j e c t s , TT, BT, BB and TB cases cons ide r ab l e 
va r i a t i ons have been d e t e c t e d . 
ELISA USING M. habana VIRRADIATED (PARTICULATE) ANTIGEN WITH LEPROSY 
PATIENT AND CONTACT SERUM (UNABSORBED) 
Both the an t igens of U. l e p r a e (au toc laved) and M. habana (Y 
i r r a d i a t e d ) were used at 0.5 OD. At t h i s level they ac ted well tor d e t e c -
tion ot an t ibod ie s in the se ra s a m p l e s . 
The serum used as a source of an t ibody remained unabsorbed 
and used as such . The r e s u l t s a r e summarised in Table ( 5 ) . 
11 
A tota l of 120 serum samples were p roces sed for the detection 
of humoral an t ibody in t h i s se t of e x p e r i m e n t s . The serum comprises of 
20 TT, 20 BT, 20 BB, 20 BL and 20 LL along wi th 20 normal heal thy 
s u b j e c t s . Ten samples of serum from contacts of lepromatous pa t ien ts and 
10 suspec ted cases of l e p r o s y were a l so inc luded in t h e s t u d y . 
Mean E.„_ va lue of 0.167 with a s t anda rd devia t ion of 0.019 492 
was obta ined for normal h e a l t h y s u b j e c t s . Cut off points for the specif ic 
diagnosis of l e p r o s y remained t h e same l i k e p rev ious e x p e r i m e n t s . It 
was determined at t he 3 conf idence l imi ts and compared from E,„_ values 
492 
of the normal h e a l t h y s u b j e c t s . 
At mean + SD (66% confidence l imi t ) 6 out of 20 (301) normal 
h e a l t h y s u b j e c t s , 9 out of 20 (45%) TT cases and (100%) of BB to LL 
cases were having d e t e c t a b l e l imi t of an t ibody in t h e i r s e r a . All the 
10 suspec ted ca ses of l e p r o s y and a l l the 10 contacts of LL had de tec tab le 
l imi ts of l e p r o s y a n t i b o d y at t h i s cut off po in t . 
At mean + 2SD (95% confidence l i m i t s ) , a p p a r e n t l y normal subjects 
were having nil de t ec t ion l i m i t , 5 out of 2^ cases in each of TT and BT 
pa t ien t s e r a had d e t e c t a b l e a n t i b o d i e s at t h i s l imit and cent percent of 
the BB to LL were d e t e c t a b l e at t h i s cut off po in t . Bes ides 7 out of 10 
(70%) were found d e t e c t a b l e in s u s p e c t e d l e p r o s y cases and again a pos i -
t i v e value of 100% was found in contact cases of LL p a t i e n t s . 
At mean + 3SD (99% confidence l imi t s ) nil value was found in 
normal h e a l t h y s u b j e c t s , TT p a t i e n t s and suspec ted ca ses of l ep rosy con-
t r a r y to t h i s 100% had h i g h e r d e t e c t a b l e l imi t s of an t ibody in BB, BL, 
LL and LL c o n t a c t s , wh i l e in BT cases 11 out of 20 (55%) was the obse r -
vab le value in de tec t ing the p re sence of \h_. l e p r a e an t ibody in serum 
sample s . 
Thus at a l l t he t h r e e cut off points (66%, 95%, and 99% confidence 
l imi t s ) BB, BL, LL and i t s contact had +ve l e p r o s y an t ibody in almost 
a l l cases d e t e c t a b l e through t h i s an t igen . 
ELISA USING M. habana LIVE BACILLI (PARTICULATE) ANTIGEN WITH LEP-
ROSY INFECTED SERUM ( UNABSORBED) 
Serum samples were a l s o p roces sed for the detect ion ot leprosy 
spec i f ic an t ibody through ELISA tes t using M. habana (pa r t i cu l a t e ) l ive 
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bacilli for coating purposes resul ts are summarized in the Table (6). 
Perusal of the resul ts at three cut off points were also analysed 
In this case. It is apparent that in case of TT and BT sera the detection 
limit was variable at three cut off points but constantly cent percent 
cases were detectable for ant i leprosy antibody in BB, BL and LL patients, 
ELISA USING M. habana (SONICATED) ANTIGEN 
a) Standardisation of optimal dilution of antigen and serum 
M. habana sonicated antigen was diluted ser ia l ly from 5 ug to 
100 ug in coating buffer and used for sensitizing the Cook's Microtitre 
plates . Each dilution of antigen was tested with all the dilutions of (1:50 
to 1:800) of reference posi t ive (+)ve and negative (-)ve serum, using 
1:1000 diluted HRP labelled antihuman IgG. 
The antigen and serum dilutions at which the difference between 
the extinction values (E ) of Ref ( + )ve and Ref (-)ve serum i . e . P/N 
ratio was highest , were considered as the optimal antigen and serum dilu-
tions. 
V7e observed a 3.06 fold difference between the (E ) value 
of Ref ( + )ve and Ref ( - )ve , at the antigen dilution 20 tig/ml and serum 
dilution 1:100 Table (7) . 
b) Standardisation of optimal conjugate dilution 
The optimal conjugate dilution to be used in ELISA test with 
th is antigen was determined by the chequer board t i t rat ion using the same 
Ref ( + )ve and Ref (-)ve se ra . Results of this t i t rat ion are presented 
in the Table (8) . It is apparent that the 1:1000 dilution of conjugate 
was optimal for obtaining a clear cut distinction between the Ref ( + )ve 
serum (OD = 0.46) and Ref (-)ve serum (OD = 0.18). At this dilution 
of conjugate difference between the OD of Ref ( + )ve and Ref (-)ve serum 
sample was found to be 2.55 fold and this was highest compared to the 
values obtained with other dilutions of the conjugate. 
ELISA REACTIVITY OF LEPROSY PATIENTS AND CONTROL SUBJECTS USING 
M. habana (SONICATED) ANTIGEN 
Serum samples from different clinical spectrum of leprosy i . e . 
from TT to LL and controls were analysed for the detection ot antibody 
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in l e p r o s y infected pe r sons using sonica ted antigen in ELISA test and r e -
su l t s a re p resen ted in Table ( 9 ) . 
For t h e normal h e a l t h y sub jec t s mean E . „ . value of 0,169 with 
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a S tandard dev ia t ion of 0.035 was o b t a i n e d . Cut off poin ts for the specif ic 
d iagnosis of l e p r o s y remained any of the t h r e e confidence l imi t s determined 
from E-n- values of the normal h e a l t h y s u b j e c t s . 492 
Thus at mean + SD (66% confidence l i m i t s ) , 4 out of 20 (20%) 
normal h e a l t h y s u b j e c t s , 4 out of 20 (201) TT c a s e s , 11 out of 20 (55%) 
BT and 12 out of 20 (60%) BB cases were found to have l e p r o s y ant ibody 
whi le BL and LL cases showed (100%) p o s i t i v i t y . 
At mean + 2SD (95% confidence l imi t s ) 2 out of 20 (20%), Normal 
h e a l t h y s u b j e c t s , none of TT, 6 out of 20 (30%) in BT and 10 out of 20 
(50%) in BB were found to have de t ec t ab le l e p r o s y an t i body ; con t ra ry 
to t h i s a (100%) p o s i t i v i t y was ob ta ined in BL and LL c a s e s . 
At mean + 3SD (99% confidence l imi t ) (E4Q2 = 0,274) nil value 
was r eco rded in normal and TT sub jec t s whi le 3 out of 20 (15%) in BT 
cases and 7 out of 20 (35%) in BB cases and 100% of BL and LL cases 
had de t ec t ab le l im i t s of a n t i l e p r o s y an t ibody in r e s p e c t i v e se ra samples . 
Thus at a l l t he t h r e e cut off points (66%, 95% a id 99% confidence 
l i m i t s ) BL and LL cases had 100% l e p r o s y an t ibody whi le res t of the 
forms of l ep rosy and normal h e a l t h y sub jec t s showed cons ide rab le var ia t ion 
in the v a l u e s . 
The compar ison of v a r i o u s ant igen in de tec t ing the percentage of 
a n t i l e p r o s y an t ibody in va r ious s e ra samples i s p re sen ted in Table (10) , 
The data r e v e a l s t ha t M. habana ant igen i s capab le of detect ing the U. 
l e p r a e an t ibod ies in the p a t i e n t s s e r a samples almost to the same extent 
as M. l e p r a e . Absorp t ion of s e r a samples of TB pa t i en t s wi th specif ic 
non-speci f ic and group ant igens removes th? t ube rcu los i s an t ibod ies beyond 
de tec tab le l imi t by U. habana ant igens but abso rp t ion of s;?rd samples 
wi th these ant igens had a l i t t l e bear ing on the detect ion of l ep rosy an t i -
b o d i e s . 
z 
* 
II 
z 11 
00 
0) 
rt-
w» 
< 
<i 
n 
o 
D 
rt-
1-1 
o 1 — ' 
, , 
z 
o 
1 
3 {U 
0) 
13 
• 
II 
•tJ 
0 
W! 
• - • • 
!-»• 
'^ < 1) 
n 
o 
3 
r r 
1 
O 
1—• 
-^^  
r 
t -
13 
0) 
r r 
(—. 1) 
'— 
n 
o 3 
r+ 
-1 
o I—" 
< 
1—• 
e 
<? 
t/i 
•• 
z 
0 
01 
3 
»-*• OQ 
'D 
3 
II 
c 
3 
00 
Z 
o 
1) 
•^ 
E: 
3 
o 
o 
Z 
o 
n 
o 
3 
c 
TO 
II 
o 
o 
o 
3 
w 
e 
cr 
w 
r* 
-( 
P 
(-»-
T) 
II 
O 
O 
1—' 
LP 
Z o o Z 
o 
o Z O 
O 
z 
o 
Z 
VjJ 
o 
o 
• 
o 
• h-' 
U> 
0 0 
O^ 
• 
0 0 
O 
• t - j 
(^  
0 0 
-) 
• 
t o 
o 
• 1—' 
I j j 
ca 
0 0 
• 
o 
o 
• I—" 
OJ 
U l 
CSJ 
• 
- J 
o 
• t \J 
t l 
• 
z 
• 
»c^  
• 
0 0 
o 
o 
^ 0 
i j ^ 
• 
o 
o 
J—" 
o 
>t^  
• 0 0 
U1 
00 
o 
I—" 
>!:> 
• 
o 
o 
o 
1—• 
OJ 
« 
a-
00 
o 
1—' z 
• 
o 
• u> 
0 0 
o 
• 
v-> 
t v 
0 0 
CM 
0 0 
O 
• 
^ (T-
O 
• I—" 
1 ^ 
O 
• i t^ 
0 0 
o 
• 1—• 
>«>. 
o 
• t j l 
N) 
o 
• 
>—' U l 
o 
• U1 
0 0 
o 
• 1—' 
~ J 
'V 
• 
z 
« 
tSJ 
• 
o 
NJ 
1—' 
o 
o 
0 0 
s^> 
• 
o 
tsj 
t\> 
o 
o 
cs> 
• 
o 
o 
tVJ 
i t^ 
o 
I—" 
o 
M 
• 00 
o 
o 
* 
09 
o 
o 
ro 
• 00 
o 
w 
l « k 
o 
• 
I—I 
tVJ 
1 ) 
* 
z 
• 
o 
- J 
>J1 
00 
o 
00 
o o o o 
03 
o 
00 
0 
• - ^ 
O 
p 
rt-
CM 
O 
3 
3 
a 
•^ I—" 
o 
3 
w 
*—. 
3 
r*-
Tl 
3 
M 
> 3 
rt-
OQ 
3 
•^ 
P) 
>-| 
n 
t l 
z 
• - ( 
e 
3 
a 
o 
3 (ft 
O 
O 
O 
O 
o 
O 
o 
00 
o 
o 
o-
S 
O 
o 
o 
c ^ 
S 
CO S 
•^  to 
(N- — ~ 
< <^-
a. S. 
s ^^ .^  
m 55 
t - s 
>.> 
(^ 1$ 
o 
6-
O 
O 
o 
s 
o 
n 
o 
o 
r+ 
•-I 
o 
Z 
o 
3 
r t 
w» 
OQ 
(D 
a 
II 
o 
o 
-«1 
Z 
o 
w 
T) 
C 
3 
2: 
O 
n 
o 
OQ 
II 
o 
o 
O 
3 
e 
cr 
M 
!1> 
II 
O 
O 
o 
00 itk 
o o 
o o 
o o 
t \ j I—i Ln 
0 0 0 
0 0 0 
O O 
o K- 00 
0 
<?> 
0 
vO 
(-• 
- J 
h-" 
0 
tSJ 
Ln 
»—• P 
r f 
P 
n 
B 
r* 
0 
0 £ 
c OQ 
PJ 
W 
iC> 
vO 
t M 
< P> 
t—• 
e (D 
0 ! 
•T3 
0 
W 
^" !-*• 
W« 
< T) 
W 
fD 
M 
e 3 
W 
i « > 
vO 
rv 
< 
»—» p (D 
W 
z fD 
OQ 
P 
r+ t—• 
< 
Tl 
W 
T) 
•-t 
C 
3 
1) 
• i 
PD 
r»-
*-•• 0 
<v 0 
Cfl 
r+ 
*-•• 
< 1> 
•^ .^  
z T) 
0 0 
1 
cr 
(N-
< ^ 
3 
s 
O 
o 
O 
"O (»^ (^. 
3 
3 
ft-(^. ( ^ 
o 
O 
o 
o 
CO 
p 
CO 
o 
s 
<>+ 
CO 
s 
m 
> 
I** 
do 03 
03 
DO 
H 
H 
e o 
cr -t 
fD 
tvj 
o o O O o 
(U 
o 
- - J 
o 
ro 
1+ 
o 
o^ 
1 - * 
U l 
1+ 
o 
l ( ^ 
lw»> 
o> 
1+ 
o 
O J 
VJ1 
U l 
1+ 
o 
to 
o 
|C>. 
1+ 
o 
h - ' 
0 0 
1 — ' 
1+ 
o 
o o o 
(VJ UJ Ul 
vO O O 
o o o 
N ) 
O 
^—N 
(—' o 
o 
olP 
M 
O 
^ • ^ 
l - " 
o 
o 
&p 
CM 
O 
^ * v 
H- i 
o 
o 
a lp 
tVJ 
O 
^ - N 
• - ' 
O 
o 
<*> 
«o 
^-^ 
,t^ 
U l 
OlP 
.^^  
- J 
O J 
t j l 
e(IP 
'~' 
-^^  M 
>^  o 
t s j 
II 
o 
I \ J 
o 
• 1 ^ 
5-
T) 
0 1 
n 
+ 
M 
a 
M 
O 
^^  I - * 
O 
o 
<*> 
C M 
o 
^^  1 — ' 
o 
o 
d P 
t>J 
O 
^^  1 — > 
o 
o 
d P 
tSJ 
o 
*^» H - i 
o 
o 
d p 
~ 1 
-^^  O J 
U l 
d P 
%-^  
d p 
ro 
o 
-^^  t - " 
o 
o 
d p 
t S i 
O 
^-»» t—' 
o 
o 
<AP 
M 
O 
»—>. 1 - ' 
o 
o 
<AP 
ro 
o 
-^^  t—• 
o 
c=> 
o>P 
<J^ 
• — * 
M 
U l 
Of 
'—' 
I—I 
o 
o 
c 
n o 
T) 
| U 
S 
1+ 
M 
o 
m 
>tk 
v O 
t v j 
tVJ 
+ 
II 
O Ui 
' D 
-^^  
w l « ^ 
v O 
tVJ 
II 
o 
t > j 
U l 
o 
f^  
m 
( U 
ri 
+ 
1*1 
C/3 
o 
z 
o 
n 
w 
•o 
o 
< 
P 
CL 
•S^  
(^  C O 
i < 
s 
m I— 
»-»< Co 
> 
(^  ra 
P 
<=s~ 
«^ 
s 
( M -
o 
p 
o 
< 5 - -
c ? ^ 
•c 
o 
<»-
s f N -
<i-
a. (^  (^  fa 
A 
3 
Q. 
• ^ o 
3 
o 
<i» 
3 p (^  
< 
p 
p 
o 
p (> < v 
C O 
s 
(~=s (^  
•cs 
^ p (^  
•c 
§ 
o p (^  
a ra 
^ p 
t ^ 
o 
1 
p 
3 
o 
< 
p 
c^ 
P 
—~ 
m •fc. 
v O 
[V5 
o 
c ^ 
C?>~. 
«^ r i 
^ ( ^ 
5 r M -
C O 
P 
a. 
<> 
o 
«>^  
("=> 
ra 
• < 3 
o 
o 
's: 
13 
P 
(^  s t ^ 
<> 
p 
a. 
s 
p 
3 
cr 
rs 
<^  
o 
«^ 
13 
O 
i > 
(^  
< 
o p (>-
H 
D3 r 
D3 
r 
03 
CD 
03 
H 
W 2 
(7) H 
0) 
t—' o j tsj tsj 1—' >—' 
^ u i o ^ ( j i 0 0 u i 
O^ t>J 0 0 CT- O^ O 1+ 1+ 1+ 1+ 1+ 1+ 
o o o o o o 
o 
w tvj 
o 
rv 
OJ 
o 
tSJ 
u> 
o 
lj>> 
t\J 
o 
UJ 
tvj 
o 
OJ 
o 
1+ 
o 
o 
u> U l U l U 1 t\) 
O^ • - ' I - " 1—' 0 0 
o o o o o 
aW> O O O c«P 
>—• olP c*0 e*> — • 
>b 
o 
dp 
tvj 
O 
CUP 
<J1 171 U l r \ j H-i 
f t— h-- (-1 ^ t \ ) 
o o o o o 
O O O oV> dio 
o«P o«P 6IP v ^ » ^ 
2 
(-4 
t -
U l IJl 
f h-" (-1 0 0 
O C3 O 
C3 <Z> lAP 
o\o cAO — . 
•"-* I—I 
o 
z 
(—1 
n 
O 
o 
c 
o 
2 
3 
1+ 
w 
D 
M 
00 W 
00 D 
" + 
o 
n 
01 
w 
W 
O 
P 
?i s < 
(^  O P 
S p ra (^ O-
—^v 
P O _ , 
r i •*!> 
CT S 
<> <t+ O 
O <^ "=>^  (^  
o- D, a. 
!»-. ra r>-. 
S ( ^ ' S ^ 
CO (^ <5>-
^ <$ 
'^  S S. 
ra 
s 5 o 
m § -^ 
- 3 ^ Go P f=> 
> <^  ^ 
rt- < O (^  p l> 
O. (^ iC 
•N. p 
p (N-
5 (^ " 
•^ ^ s S rt-
co <> 
12: P 
s 
a. 
5 -
P :s 
cr P 
P 3 S cr P ra 
•^ 
73 
^ <*^ 
tN-
i»^. 
O ^ 
P o ( ^ (> p <^. 
(M- (*<• 
( ^ 1 ^ -
< 
—^ ra 
- N 
<j.. o $ P (ii C-
p ri 
1 O 
n (^ 
o o 
_ 3 f r+ 
t^  S 
n 
r+ 
n 
(U 
w 
n 
en 
r/i 
c 
w 
n 1) 
n 
a 
r D3 
r 
CD 
a 
D3 
H H 
o 
IS) 
o 
N) 
o o o 
w 2 
e O 
cr -t 
n g 
01 
N) 
o 
h-' U J t\J tVJ tSJ M >0 
O O O O O O - ^ 
-^ -^ -^ ~^ -^ — ^ 
! - • ( _ . ! _ . | _ i !_• ,_ j t j , 
O O O O O O 1 ^ 
O O O O O O v - -
olP OP o¥> CPP e»p cip 
o 
o 
dp 
^ 
^ - N 
~ J 
O 
•*> 
>—' 
t \J 
o 
^ h-' 
o 
o 
<*> 
I>J 
o 
—^. h-' 
o 
o 
OlP 
tsJ 
O 
^^  1—' 
o 
o 
dP 
Ln 
^^  OJ 
t n 
<*> 
—' 
t j i 
-^ tSJ 
U 1 
d p 
^ 
z 
r 
o 
o 
OlP 
7^  
h-( 
t r 
ts j 
o 
^ v 
1 — < 
o 
o 
ctp 
f O 
o 
-—». 1—' 
o 
o 
dip 
rvj 
o 
^—«. 
H-' 
o 
o 
oP 
1—' 
I—" 
'^ U l 
U l 
oP 
7', 
l-H 
r 
I—I 
t\J 
U l 
U l 
1+ 
o 
o 
1—' 
iji 
NJ 
o 
o^ 
1+ 
o 
o 
1—1 
M 
o^ 
OJ 
-^  1+ 
o 
o 
l b 
o 
LH 
U l 
ISJ 
1+ 
o 
o 
l b 
o^  
l b 
U l 
o 
1+ 
o 
o 
OJ 
N> 
tSJ 
CO 
l\> 
1+ 
o 
o 
N ) 
- J 
H-" 
- J 
U ) 
1+ 
o 
o 
N ) 
l b 
1—' 
o-
- J 
1+ 
o 
o 
t - l 
o 
tsj 
1+ 
C/3 
o 
o 
I j j 
o 
dP 
M 
l b 
II 
O 
1—' 
2 
n 
+ 
w D 
o 
o 
e 
I? z 
0) o 
W 
w 
l b 
vO 
II 
O 
l\> 
o 
U l 
s 
'V 
3 
+ 
CVJ 
Ui 
O 
n 
01 
•o 
o 01 
1^ 
<-t-
< 
" + 
•^ D 
l b 
Z 
o 
o-
I S 
5-
P! 
cr 
P 
s f5 
"G § 
tM-
i < . 
O 
h P (^  r i 
^^ 
^ 
!» - . 
. i l 
A 
P 
0-
P 
fa 
0 . 
p 
CO 
s 
<v. 
s 
m 
r-
> 
t^ 
fa (> (^ 
P 
s $x 
s p 
5 
cr (^  
<^  
o 
T5 
o 
l * ' . 
(M-
< 
ra 
o 
p 
o-
ra 
c>-
p 
Q-
1 ^ . 
<3>^ 
rs 
o p (*+ 
o 
<=s. 
o (»-. 
s 
e-t-
O-
O-
ra 
<ir 
5 (»-. 
s 
ra 
sx 
5 
o 
3 p (^ 
< 
p ( ^ 
p 
rs 0-
S 
t ^ . 
s tCi 
2 
p 
P 
;s 
O 
o 
< p (^ p 
r5 
o 
rn 
•fc» 
•o 
t v i 
o 
«-^  
a. 1 ^ . 
(^  
;s (*+• 
(o 
rT 
P 
EL 
(> 
O 
< 3 ^ 
( ^ ( ^ 
o 
<> 
"(3 
P tM-
!»~. r i 
s (^  
<> 
<> p 
(> 13 
r i 
o 
p 
o 
o 
s (N-
p 
o 
<»+ 
o 
r~ 
p 
<^ . (^  
r 
r 
do 
t -
CD 
03 
CD 
H 
H 
H 
w z 
e o 
rn 3 
O O o O o 
U 1 
0 0 
^o 
1+ 
o 
o 
U 1 
t n 
i ^ . 
- J 
-a 
1+ 
o 
o 
>^  U l 
cvj 
vO 
o^ 
1+ 
o 
o 
i t^ 
N O 
fVJ 
I—" 
U l 
1+ 
o 
o 
OJ 
1—1 
*-• 
- J 
- J 
1+ 
o 
o 
tvj 
o^ 
O 1+ 
o 
o 
1—' 
tVJ 
o 
•^^  I - " 
o 
o 
otB 
tvj 
O 
/—^  1—' 
o 
o 
«(o 
t\J 
O 
*—^  1—' 
C3 
O 
d o 
I—" 
vO 
- - X 
vO 
l / l 
dP 
* w 
vO 
^^  l^w 
U1 
olP 
_^^  
iC> 
NJ 
O 
OP 
. 
NJ 
O 
^^  1—' 
o 
o 
c*» 
rv; 
o 
-^^  )-' o 
o 
&p 
tVJ 
o 
^^  I—" 
o 
o 
t*p 
1—' 
N) 
^^  CT» 
O 
olP 
—-
0 0 
iC' 
o 
<*> 
^^  
h-l 
tr 
M 
O 
^ - N 
h-" 
O 
o 
OHO 
IS) 
o 
-—^  I—' 
o 
o 
OV> 
ts) 
o 
-—* h^ 
o 
o 
dvo 
sO 
•—^  >c> U l 
eW> 
— 
1 — ' 
.—, U l 
o\P 
> 
z 
H-l 
o 
0 
c 
tJ 
i? 2 
to . 
t 
s: 0) 
p) 
3 
1+ 
r/) 
O 
m i ( k 
vO 
^ d 
W 
ro 
II 
o 
1J1 
2 
(U 
u> 0 
+ 
t\} 
^"^ S 2 
M S 
11 + 
2 
0 
o 
W 
W 
•D 
O 
0! 
< 
CT 
R. f^ 
^ 
— 
ra 
s 
t » - . 
s 
rri 
r~ 
> 
( N . (^  (> (M. 
Q-
fa 
S 
(^  
o 
p (^  
o 
c ^ 
c ^ 
Q 
<> 
0-
ra (N-
ra 
^ 3 
CL 
O 
3 
o 
.^  3 p 
<^  
< 
s 
CO 
2: 
s-R 
C3-
T3 
<*+ 
<^ . O 
c (^  R 
e-t-(^  
-^ 
r-
r < . 
c (^  
2 
s 
o 
< 
p 
r i (> 
•^ "^  
rn 
-;^  
< i 
N i 
o 
< : ? ^ 
a. 
<>-
«^ rs 
^ 
o 
<s^ 
(^  (^  
•<3 
o (> 
iC 
•<3 
1 ^ . 
P 
p 
3 
o 
"G 
o 
<> r»~. 
e-v r^. 
< ra 
o 
p 
<> r i 
o-
1) 
a 
n 
O 
o 
P 
rl-
o 
w 
ro 
< 
e 
0) 
•^ 3 
M» 
oo 
2 
« 
II 
2 
•D 2 
+ 0 
II n 
o 
•vB. 
2 
o 
<u 
a 
T) 0 J- OQ 
" • ( D P 01 
< 
1) 
n 
o 
t3 
II 
M O O 
• - • ! _ . I—' 
< 1) 
1) 
II O 
n • 
O o o 
a • o^  
i-c O • • 
o o 
Z 0) 
c 
3 
a> 
B 
2 
O 
1 
3 
a- 3 ° 
3 •< 1) 
P 
3 
o- 2" 
o > -
c 
3 
r 
0>> 
00 
o 
o 
- 4 
tvj 
o 
o 
o 
o 
o 
o 
t—» 
•• I J l 
o 
0 0 
T) 
•-( 
c 3 
a 
1—• 
o" 
D 
n > 
f 3 
3 %• 
r-t- *— 
• I OO 
Pi T) 
r r 3 
3 ? )->• 
-^ ^ t \ j 
• o^  
o 
~—' 
VA> 
^O 
o 
• !—• 
^ - v 
NJ 
• 
><^  
« J 
-^' 
>«>• 
CM 
o 
• 
•—' 
--^  M 
• >b 
-^  
•— 
>«» 
-a 
o 
• t - ' 
^ • ^ 
I \J 
• U l 
^ 
—' 
4 ^ 
>o 
o 
• t - l 
•^^  M 
» 
>«> 
-^  
~^  
l / l 
fs j 
O 
• tVJ 
vO 
tVJ 
^^ 
- J 
o 
tSJ 
***^  o 
1—' 
C\J 
U l 
CD 
'"^  o 
- 4 
M 
0 0 
0 9 
O 
- J 
rvj 
o 
o 
o 
o o 
M 
• 
—' o 
• 1—' 
N ) 
• 
~-^  o 
• 
M 
• 
~^  
0 0 
o 
• 1—' 
OJ 
• o 
t7> 
• - ^ o 
• I—" 
VJl 
tV) 
• 
(J l 
-^^  o 
• 
M 
(J i 
ro 
- 0 
00 
ro 
• ro 
C3 
O 
O 
t M 
• 
O 
o 
o 
tS) 
• t—• 
' o 
cu 
00 
o 
CM 
oo 
2 
TJ 
•n 
TD 
o 
o 
T : 
oo 
Ul 
o 
00 
U l 
OQ 
O 
OQ 
OQ 
OQ 
p 
a. 
N 
P 
( ^ . 
O 
(> 
(^ O 
!= 
3 o 
Is- P 
o 
^ o 
o 
s 
o 
rs 
eg 
p = 
o 
p 
<> o 
o 
p 
<*+ 
p 
S 
CO 
p 
> 
(^  p 
. ( ^ 
P 
cr 
P 
;s 
P 
P 
( ^ . 
CO 
p 
o 
p 
»—' 
•< 
tft 
cr 
i-t 
P> 
r* 
m 
II 
o 
» o 
o 
-o 
Z 
0 
o 
0 
^ 
(-^  fS 
II 
o 
• o N) 
O 
Z 
0 
M 
<1) 
i-t 
3 
II 
o 
• o 
>(^  Ul 
n 
o 
O 
< 
e 
1) 
z 
o 
p 
3 
r t -
OQ 
P 
II 
O 
O 
O^ 
00 
o 
o 
o 
o 
o 
o 
t^j H-' ^Jl 
o o o 
o o o 
o o 
a-
o O l - J I—I 
O o ( jn 0 0 
)—I t \ ) 
0 0 U 1 ( - • 
L n ON 
(—• 
c r f 
M * 
0 
p (/! 
(B 
• ^ 
m 
P 
r+ 
o 
o p 
c 00 
p> 
w 
>«>. >o 
tV) 
<! (1) 
1—* 
p 
•xi 
o 01 
t — 
r+ 
h * -
< (D 
0) 
e 3 
W 
>tk 
vO 
CVJ 
< (11 
h—» 
c fD 
[ / ! 
Z 
0) 
oo P) 
i - t-
M -
< (B 
W 
m i-t 
c 3 
o 
01 
p> <p 
r*- '— 
O ^ 
OQ 
(a 
< 
n 
cr 
09 
m o 
s 
O 
o 
Q 
•c 
3 
5 
G. 
< ^ 
C 
o 
o c^ 
o o 
CO 
o-
s 
ft 
< 
Ln 
o 
o 
CM-
s 
to 
t -
tr-
D3 
tr 
tD 
t3D 
m 
H 
H 
H 
w Z 
si 
LI • -
O O O o o O 
1 ^ 
0 0 
1—• 
1+ 
o 
o 
i t k 
0 0 
>l^ 
o 
t \J 
1+ 
o 
o 
• ^ 
- J 
ro 
i t ^ 
OJ 
1+ 
o 
o 
o^ )-» 
cv 
t—' 
OJ 
1+ 
o 
o 
>^  
v*> 
)-' 
- J 
i C ^ 
1+ 
o 
o 
t \J 
\*) 
1+ 
O 
O 
M M I—' 1—' >*^  
O O tVJ 1—' —» 
»—' H-" O^ Ln O 
O O O U1 <*> 
o o < *><*> •--
dp 0*0 — ^ ^ 
O 
ts) 
O 
O 
O 
t>0 - ^ LO Z 
O • — — V l -H 
--^ u j v-j f 
O o\P <*P 
O ^ ^--
z 
l - l 
r 
o 
e 
n 
w 
2 
O 
T) 
3 
1+ 
W 
I\J 
o 
/—V 
I- ' 
o 
o 
aV> 
tVJ 
O 
*—% 
!—• 
o 
o 
e*P 
1—' 
O 
-^^  Ul 
o 
cdo 
^~' 
O^ 
t ^ ^ 
Ul 
o dp 
s..^ 
Z 
t-i 
c-
M 
^ I-" 
C 
dP 
-^^  
tt 
1, » 
o + 
o O 
N) 
rt 
w 
Z 
o 
n 
(ft 
tn 
T3 
O 
l » ^ . 
s 
m a. 
r- r<-
* - 4 < : ? ^ 
Co "S^-
> ? 
^ (^ 
(M-
o p (^ 
o 
~ti 
o 
<<. s (N-
0-
a 
r5 (>+ 
ra 
3 
(^  
n. 
o 
3 
s 
o 
r* 
3 55 
0 ^ 
< P (^ P 
e 
<> !» . . 
s CO 
IS 
S-
P 
o-
R 
s R 
—^.^  In 
o 
s 
<^ . o 
R (N-
(^  
sx 
R 
S 
i M -(^ . CO 
ra 
s 
2: 
o 
a 
< 
!^ R (^  
i > 
rn 
4i^ 
•O 
I--3 
O 
«^ 
a. 
i v . 
<=^  e ^ 
CO (^  
0-
o 
c^ 
(^ (^  
"CS 
,^  
o 
<> 
^ 
• (3 
R f M -
i < . 
ra 
s 
ei-
d-
R 
s 
sx 
s R 
3 
o-
ra 
A 
o 
<s--
"C3 
o 
l> 
r^. 
1 ^ . 
< 
r2 
o R 
i> 
oa 
<> 
P O 
a 3 
cr 
(A 
o 
i-i 
cr 
1 
a 
w 
o 
0> 
a 
3-
p» 
cr 
3 
PJ 
a-
w 
o 
•1 
cr 
cr 0) 
o 
»—t 
3 
cr 
w 
o 
cr 
cn 
cr 
3 
7^  
^12 
c 
( - » • 
o 
< 
(I 
cr 
?« i . 
pi 
a 
a 
-^' -i 
a 
1 
a 
IVJ 
o 
dP 
ib. 
U l 
oiP 
>«k 
^J^ 
dp 
>C> 
U i 
cW" 
>b 
O 
a<> 
Ul 
UT 
o\o 
vO 
tn 
<*<> 
1—' 
O 
o 
(—' 
O 
o 
00 
O 
C«l° 
o O 
o 
OP 
o 
o o 
o 
o 
o 
o 
o 
olP 
O 
o 
df> 
O 
o 
<*> 
o 
o 
1*> 
o 
o 
<*> 
o 
CD 
0*9 
O 
o 
o 
o 
aW3 
O 
o 
o 
o 
o 
o 
dP 
o 
o 
O 
CD 
H 
D3 
cn 
r 
1-1 0) 
n 
^ c 
tj n 
(/! 
1) 
tr. 
H 
D3 
•n 
o 
3 (-+ 
D-
ft 
r+ 
ft 
O 
o 
3 
13 
O 
01 
< (I 
o 
pi 
cn 
(D 
lA 
s: 
D 
cr 
(>o r> 
<5 (it 
<> 
3 
• Q 
o 
5 
(> 
o 
(•<=> S 
f= 
o 
* 
Q 
c^-. 
F i g . l : Showing the p r i n c i p l e s of Enzyme Linked Immunosorbent Assay 
(ELISA) 
F'p 
Fig.2: Showing the ELISA posi t iv i ty for different grades of Leprosy 
antibody and normal healthy serum using M. habana antigen. 
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Out of the two sero-diagnostic methods, the Radioimraune assay 
and the Enzyme Linked Immunosorbent assay in the diagnosis of leprosy 
one is preferred over the other by different laboratories . 
For a re la t ively high degree of specif ici ty, sensitivity and 
reproducibi l i ty the Enzyme Linked Immunosorbent assay (ELISA) may be 
used as a replacement of radioimmtine assay (RIA) as also proposed by 
Rogerekins (1976), Watson (1976), Voller (1978) and Savigny and Voller 
(1980). The major problems in RIA is the costly reagents, short self-
life of the conjugate, poses health hazards and requires highly skilled 
persons to carry out the t e s t . These disadvantages have been eliminated 
in the ELISA test since i t is s imple, reagents are comparatively cheaper, 
can be performed at ease by one and a l l , results can be read conveniently 
and is reproducible . Due to these reasons ELISA has superiority over 
RIA for the sero-diagnosis of infectious diseases , Landon, (1977). 
Conventional ELISA has been carried out by several workers 
(Bos et^  al_., 1976; Yang and Kennedy, 1979; Speiser 1980 and Jyotsna 
et a l . , 1985) for the sero-diagnosis of infectious diseases . We have also 
chosen this test for sero-diagnosis of leprosy for the reasons of i ts virtues 
which it possesses over other t e s t s . 
In ELISA system background reaction is an important factor which 
can be overcome by the use of Tween 20 and Bovine serum albumin (BSA) 
(Voller, 1974, 1975 and Bullock and Walls, 1977). We used successfully 
BSA to alleviate the nonspecific binding which increased the flexibility 
of the tes t . 
Foremost important aspect of ELISA is the selection of antigen 
for the detection of antibody in leprosy. Whole cell M. leprae antigen 
and phenolic glycolipid (PGL-1) has been used successfully to detect 
antibodies in leprosy. These antigens are available in limited quantities 
in specified laboratories since M. leprae has defied all aspect of in 
vitro cultivation and _m vivo sources of NI. leprae is limited and constantly 
dying out tor mass ava i lab i l i ty . 
With this view in mind, we selected to use some antigenicall y 
related mycobacteria which can detect M. leprae antibodies to a consi-
derable extent. One antigenic strain ot mvcobacterium, designated M. habana 
26 
has shown vaccine protection against live M. leprae challenge in the mouse 
footpad as well as antigenic cross-react ivi ty with M. leprae antigens. 
This strain is cult ivable ^H vi t ro and easier to obtain in larger qnantities 
for any purpose. Since diagnostic value of M. habana antigen was precisely 
not known in detection of M. leprae antibodies from human patients sera, 
th is test was conducted using different preparations of M. habana. We 
have used this Mycobacterium in three physical states - the live, the 
Yirradiated and the sonicated one and have compared with M. leprae 
whole cell antigen. 
Several workers (Miller et_ al_. , 1983; Young and Buchanan, 1983; 
Douglas et^  a\_. , 1984 and Abreu & Gonzalez 1987) have used wet-method 
system for the coating of ELISA plates with M. leprae and phenolic glyco-
l ipid antigens and have obtained reproducible resul ts for the sero-diagno-
sis of leprosy. The wet method for coating was also used by us and 
it has worked well in our system. 
It is known that chronic infections or hyperimmunization frequently 
results in the production of antibodies to common antigenic determinants 
which masks the reac t iv i ty to more specific determinant. The antibodies 
to common antigenic determinants (group specific) have to be eliminated 
first to obtain specificity in the test system. Mycobacteria as a class 
possess group specific antigens, which lead to the production of antibodies. 
Conclusive evidence of nearly monospecificity of the serum samples under 
test can only be obtained if the test serum is absorbed with nonspecific 
and specific antigenic determinants to make it nearly monospecific. In 
our test system we used the sera samples in two different ways. In one 
system we used unabsorbed sera and in the other the absorbed one. Various 
antigens used to make the serum nearly monospecific comprised of lecithin, 
cardiolipin, M. bovis (BCG Ph ipps ) , M. tuberculosis H Ra and M. vaccae. 
The method followed for absorption was that described by Abe ex_ a\_. 
(1980) for removal of cross reacting antibodies. 
The selection of particulate antigen for coating of the ELISA 
plate depended on the premise that cell surface antigens should be easily 
recognised by the immune system ot the host. It is also possible that 
antigens which have been extracted from cells may either have altered 
determinants or have been denatured in the process of extraction (Doughlas 
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et^  al_. , 1984). Another possibi l i ty for concentrating mainly on whole cell ' 
antigen in this study was based on the fact that extracted antigens may 
not be presented in the immune assay in the same way as they are pre-
sented on ce l l s . 
The live bacill i of M. habana and Y-irradiated bacilli of the 
same strain had precisely no descernible difference in detecting the lep-
rosy antibody in patients se ra . This might be largely due to the fact 
that Y^irradiation of the cell did not result in morphological changes 
as seen in the light microscope. The treatment ( Y irradiation) does not 
seem to interfere with the whole cell presentation of the antigen in micro-
t i t re plates for the detection of antibody. The same bacterial antigen 
in the sonicated state has lost some of its property in detecting M. leprae 
antibodies in TT, BT and BB cases and at Mean + 3SD cut point it could 
detect antibodies in only BL and LL patients sera which are known to 
contain high concentration of ant ibodies . Thus lower levels of antibodies 
were not easily detectable by the sonicated M. habana antigen. 
M. habana antigen in ei ther form (live and Y* irradiated) was 
able to detect M. leprae antibody in both unabsorbed and absorbed sera 
samples to a considerable extent. The removal of group specific and non-
specific antibodies in the serum samples had l i t t le effect and M. habana 
antigen was capable of detecting considerably high percentage of positive 
leprosy cases par t icular ly from the upgrading side of the spectrum of 
the Ridley Jopling (1966) scale of leprosy. The absorption of the 5era 
samples with specific and non-specific antigens does seem only to have 
some effect in detecting only few cases in the down grading reactionary 
state that is TT and BT forms. The results have indicated that besides 
group specific antigen to mycobacteria, M. habana does possess some 
more common antigenic determinants to M. leprae, that is why it is capa-
ble of detecting almost similar percentage of cases of leprosy as is being 
done by M, leprae . The ^ i r radia ted antigen was slightly better over 
live bac i l l i . The high react iv i ty of M. habana Y irradiated particulate 
antigen may presumably be due to the reason that killing the bacilli 
by Y irradiation might have removed a mycoside like material from the 
surface ot the organism in a way similar to that of heat induced loss 
of surface electron Transparent zone trom M. lepraemurim reported by 
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Draper and Rees (1970). Loss of this zone in ^^ irradiated M. habana 
component may have exposed surface components which might have been 
easily recognized by the antibodies in the sera of LL patients. When 
the tuberculosis pa t ien t ' s sera samples were absorbed with specific and 
non-specific antigens including M. tuberculosis H Ra antigen, the sensiti-
vity of U. habana to detect M. tuberculosis antibodies was considerably 
lowered and at Mean + 2SD and Mean + 3SD cut off points no TB cases 
could be detected by M. habana antigens, even at Mean + SD cut off point 
the E values in Tuberculosis patients absorbed sera was considerably 
low. 
In comparison, the two antigens namely M. leprae particulate 
and M. habana part iculate seem to have closer relationship in detecting 
M. leprae antibodies even after absorption of non-specific antibodies from 
the sera sample of leprosy cases . Some more work is warranted before 
a conclusive evidence is drawn about M. habana for predicting its diagnos-
tic value in leprosy which is in progress . 
SUWARY 
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An enzyme linked immunosorbent assay was developed to detect 
Mycobacterium leprae antibodies in the sera of various grades of leprosy 
patients. An antigenically related Mycobacterium M. habana was used in 
thiee physical s ta tes to detect M. leprae ant ibodies . Gamma irradiated 
whole cell of M. habana had the highest percentage of detecting M. leprae 
antibodies. M. habana antigen was capable of detecting M. leprae anti-
bodies even in nearly monospecific leprosy patient sera obtained after 
absorption of non-specific antibodies with leci thin, cardiolipin, M. bovis 
(BCG) and M. tuberculosis (H _Ra) antigens. A comparison was made with 
M. leprae antigen using the same set of sera samples. 
M. habana antigens were able to detect almost equal percentage 
of antibodies from the patient sera as M. leprae antigens. M. habana 
antigens as an al ternat ive to M. leprae antigens in detecting M. leprae 
antibodies in ELISA system, has been discussed. 
IMMUNOGLOBULIN PATTERN IN SERUM 
REVIEW OF LITERATURE 
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Infections with Mycobacterium leprae leads to the production 
of disease only in a fraction of population. These infected persons become 
poor in competency of clearing the bacil l i and remain a carrier of the 
bacillus for quite long time or even upto whole life time. Even with 
treatment, bacteria may remain detectable for years . In this kind of 
chronic disease , some of the pathological effects are ought to be caused 
by an interference with normal immune regulation as a result of long term 
interaction with persistant antigens. 
The disturbance in cell-mediated immunity may be related to 
the inabil i ty of the host to cope with infection by M. leprae (Bjune 
e£ aj_., 1983). Properties of different types of antibodies and the presence 
of antibodies not related to the specific immune response, such as autoanti-
bodies , are indicative of the ac t iv i t ies of the regulatory cells and may 
play a part in regulation of immune responses. 
Previous studies of humoral immunity in leprosy patients have 
demonstrated changes in patients compared to controls with respect to 
the levels of IgG, IgM, IgA (Bullock et_ al_. , 1970; Turk et^  al_., 1971; 
Bullock £ i a]_. , 1982), and IgE (Nuti et_ al_. , 1982). 
Studies of antibodies to autoantigens in leprosy patients have 
given different resul ts in different patient populations. The frequency 
of autoantibodies has been found to be increased in lepromatous patients. 
(Petchclai et^  al_. , 1973; Wright, 1973; Rea et^  al_. , 1976; Masala et^  al_., 
1979). 
In developing countries, the variety and quantity of antigenic 
stimulation result in an immunological profile somewhat different from 
that seen in the Industr ial ised countries. These changes include elevation 
of serum level of IgG, IgM, IgA and some autoantibodies (Greenwood & 
Whittle, 1981). 
Wright et_ al_. (1985) reported a considerable increase in IgG 
in the Vietnamese controls compared to the controls from Netherlands, 
IgM and IgA were also elevated and IgE was greatly increased. Bullock 
et a l . (1970) reported an increased level of IgG and IgA but not IgM 
level in patients at the lepromatous pole. Increases were also reported 
in lepromatous leprosy by Turk and Bryceson (1971). 
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In a s e r i e s of s t u d i e s Kelkar et^ £1^. (1979) have found the IgG 
l e v e l s usual ly i nc rea sed in both lepromatous l e p r o s y (LL) and tuberculoid 
l e p r o s y (TT) p a t i e n t s , whi le IgM and IgA were inc reased only in LL pa-
t i e n t s . Although t h e r e i s some va r i a t i on among the se s tudies but later 
s t u d i e s in India (Harakr i shnan et_ aj_. , 1982; Lakshamana e_t^  al^., 1982), 
demonst ra ted i n c r e a s e IgG, IgM and IgA in lepromatous l eprosy bat not 
in Border l ine or Tuberculo id l e p r o s y pa t i en t s (Wright et a l . ,1985). 
The LL pa t i en t s under DDS t rea tment for sometime, had signifi-
cant i n c r e a s e s in serum l e v e l s of IgG, IgA and IgM in comparison with 
c o n t r o l s , whi le the BT pa t i en t s d i f fe red from con t ro l s only by an increase 
in IgG (Wright et_ aj_. , 1985). 
Nuti et_ al_. (1982) found both TT and LL pa t ien ts to have signi-
f icant ly i nc rea sed IgE l e v e l s , and t h e LL pa t i en t s had significantly more 
IgE than d id t h e TT p a t i e n t s . According to Wright et_ al_. (1985), only 
the LL pa t i en t s group had s ign i f ican t ly more IgE than control groups. 
Out of the s e v e r a l d i s c r e p a n c i e s in r e s u l t of serum immunoglobu-
l in l eve l in l e p r o s y , t he r e s u l t s ob ta ined in lepromatous forms of leprosy 
(LF) which inc ludes BL & LL, have been more consis tent than those ob-
ta ined in non- lepromatous forms (NLF) which inc ludes BT, TT and BB 
l e p r o s y , (Bergot et^ al_. , 1963; Lim & Fusa ro , 1968; Bullock et_ al^., 1970; 
Sr i s inha ei^ al_. , 1972; S r i v a s t a v a et^ al_. , 1975; Youngchaiyud ex_ al_., 1975; 
Pe tchc la i et^ a]_. , 1977) . 
An o v e r a l l i nc r ea se in t h e l eve l of IgA p ro t e in s have been r epo r -
t ed by Bullock et_ aj_. (1970) , S r i s inha et_ a}^. (1972) , Sr ivastava et_ al_. 
(1975) , Youngchaiyud et_ ai[. (1975) . 
Bullock et_ £]_. (1970) , S r i s inha et_ a^. (1972), Srivastava et_ 
a l . (1975) have given i n c r e a s e d va lues for IgD p ro t e in s . But several 
ot the o t h e r w o r k e r s have found c o n t r a d i c t o r y r e s u l t s and serum IgA 
has been found to be normal by Lim and Fusaro (1968) . 
The family s tudy demons t ra ted a d i s c r e p a n c y in the resu l t s 
ob ta ined from Nor thern pa r t of T h a i l a n d , in which only IgG and IgA were 
found to be s ign i f i can t ly i nc rea sed in LF among those having disease 
for 5-10 y e a r s , and the i n c r e a s e of IgM only in those with y'lO years 
ot d i s e a s e , (Ch iews l ip et a l . , 1985). 
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The random study of LF, from Central Thailand displayed clearly 
the effect of treatment upon serum immunoglobulin level . Serum IgG, IgA 
and IgM decreased gradually after prolonged treatment and these changes 
were most notable in IgM. Bullock £t_ al^. (1970) have tried to correlate 
the serum immuoglobulin levels with treatment in which similar results 
were obtained indicating a decreased serum IgM level after treatment. 
IgM antibody response is most l ikely to be present when a stimulating 
antigen remains in the host and adequate chemotherapy may decrease the 
antigen load which may result in a decrease in the serum IgM. 
There has been more controversy in the result of serum immuno-
globulins in NLF leprosy. Serum IgG, IgA and IgM in NLF were found 
to be normal by Bullock et^  aj_. (1970). Youngchaiyud et_ al_. (1975) and 
Lim and Fusaro (1968), whereas results reported by Chiewslip et_ aj_. 
(1985) from Central Thailand in the random study showed only significantly 
increased IgG and IgA resu l t s . The serum immunoglobulin level in NLF 
were less affected, when compared with LF (Chiewslip et_ al_., 1985). 
IgA in NLF was significantly decreased in early cases and increased after 
prolonged treatment. 
Many workers have studied the serum level of immunoglobulins 
in reactional and non-reactional state of leprosy patients (Jha et_ a l . , 
I97I; Saha & Mittal, 1972; Welsh et^  al_., 1973; Kelkar ex^ aU, 1979 and 
Sengupta et_ aj^. , 1979). They have largely reported increased level of 
IgG in lepromatous leprosy patients during both reactional and non-reac-
tional leprosy pat ients . 
Erythema Nodosum leprosum (ENL) is a serious complication, 
seen in highly bacilliferous leprosy patients (Rea and Levan, 1977 and 
Bullock, 1978). I ts immunopathogenesis based on circulating and tissue 
deposited immune complexes has been well documented (Wemambu et_ al . , 
1969; Bjorvatn et_ aj_. , 1976). An increased prevalence of organ specific 
as well as non-organ specific autoantibodies has been shown during ENL 
reactions in LL leprosy , although an immunological profile of serum immuno-
globulins and autoantibodies after the subsistence of the ENL has not 
been adequately studied (Jha e_t_ al_. , 1971; Saha et_ aj_. , 1975; Kelkar 
et^  al_. , 1979; Sengupta et^  al_. , 1979). 
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Bullock and coworkers (1970) found that IgA, IgG and IgM. were 
significantly increased in sera of patients with LL as compared with 
patients with tuberculoid leprosy and control subjects of the same racial 
and geographical group. 
MATERIALS AND METHODS 
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CHEMICAL USED 
Tripartigen plates were purchased from Hoechst Pharmaceuticals 
Limited, Bombay (India) . 
SERUM 
Source of serum comprised of 5 ml venous blood, from each 
patient drawn asceptically from various grades of leprosy patients through 
the courtesy of Mission Leprosy Hospital, Barabanki. Blood samples were 
kept at 37°C for 2 hr and then 4°C overnight so as to obtain maximum 
quantity of serum, which was collected in 0.1 ml aliquotes. A total of 
145 male cases of various grades of leprosy pat ients , residing around 
Barabanki Leprosy Mission Hospital were included in the study. 
These comprised of 85 cases treated with DDS (4,4'-Diamino-
diphenyl sulphone) from 6 months to 2 4 months and remaining 60 cases 
were having treatment with DDS upto a duration of 2 to 5 years . 
The primary diagnosis was es tabl ished in each case according 
to c r i te r ia fixed by Ridley and Joping (1966). 
Cases from all forms of leprosy were included in the study. 
They comprised of 26 cases from Tuberculoid (TT) group, 26 cases from 
borderl ine Tuberculoid (BT), 26 cases from Intermediate group (BB), 
26 cases from Borderline lepromatous (BL) and 41 cases from lepromatous 
(LL) group. 
The age of the patients ranged between 11 to 60 yrs . The control 
cases consisted of 25 normal healthy individuals from non-endemic areas 
having no familial h is tory of ancestral leprosy. 
QUANTITATION OF IMMUNOGLOBULINS 
This was done by the method of radial immunodiffusion (Mancini 
e^a ]_ , . 1965; Kelkar et^  al_. , 1976). 
A standard serum (commercially avai lable : Hoechst Pharmaceu-
ticals L t d . ) , was used to calibrate a local serum pool and suitable dilu-
tions were made and used as s tandard. The test was performed by using 
tr ipart igen pla tes . 
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PROCEDURE 
The t r ipar t igen plates were init ial ly opened for 5 mts. at room 
temperature for evaporation of any condensed water present in the wells. 
Undiluted serum samples were used for the determination of IgA and IgM, 
whereas for IgG and control serum immunoglobulins determination, the 
serum was diluted to 1:10 with isotonic saline. 
Well -No.l, in the plate was filled with 5 fi l i t of the control 
serum and wells from 2 to 12 were filled with the respective sera under 
tes t . 
The plates were t ight ly closed and left at room temperature 
for diffusion. Evaluation have been made after a minimum diffusion time 
of 50 hr (IgG and IgA) and 80 hr (IgM). 
At the end of specified diffusion time the Diameters (D) of 
the precipi t in rings were measured using a suitable calibrated instrument 
supplied by the firm. 
RESULTS 
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The samples of serum used for the quantitation of immunoglobulins 
were obtained from almost all forms of leprosy of the Ridley-Jopling 
scale (1966). To have a general idea about the pattern of Ig samples 
from all age groups were included. The patients had a normal treatment 
course with DDS to a period ranging from 6 months to 5 yrs . For conve-
nience and for determining the short and long term therapeutic effect 
on the level of immunoglobulins whole treated group was divided into 
broad based groups comprising of 6 months to 2 years and more than 
2 years to 5 years (Fig. 3 ^ ^ )• ^^1 the samples were processed under 
identical conditions to avoid variation and e r rors supposedly non-specific. 
There seems to be a general r i se in the level of IgG in all 
forms of leprosy over control, i r respect ive of the treatment received 
from a 6 months to five years (Table 11). 
The highest level of IgG was recorded in LL patients having 
treatment upto 6 months to 2 years when compared to different forms 
of leprosy in both t reated groups as well as controls. 
The lowest level of IgG was recorded in BL patients in the 
group treated with DDS from 2-5 years . But when we compare the level 
of IgG in i ts respect ive group between different forms of leprosy the 
highest level of IgG was recorded in LL patients and the lowest level 
have been recorded in BT patients in group treated with DDS (6 monihs-
2 years ) , while the res t of the forms remains of the intermediate value 
in between the two. 
In 2-5 year DDS treated group the highest level of IgG was 
noted in TT pat ients , while the lowest level was noted in BL patients 
and in between these two values l ies the other values of the rest forms 
of leprosy (Table I I ) . 
Contrary to th i s the level of IgG proteins seem to have fallen 
after 2-5 years treatment with DDS in all forms which is significantly 
decreased in LL than to the groups treated with DDS (6 months to 2 
year) . 
The level of IgM and IgA have also indicated a rising trend 
over controls, although there is considerable increase in the levels of 
these •immunoglobulins in lepromatous cases (Table 12,13). 
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An overall level of IgM in the patients treated with DDS upto 
6 years has shown sl ight ly decrease when compared to the groups having 
treatment upto 2 years . The general level of IgM has shown increasing 
trend in all forms of leprosy over control (Table 12). 
The general level of IgA proteins also (Table 13), has a rising 
tendency in diseased group over controls, i r respect ive of the treatment 
received from 6 months to 5 year, (Table 13), but there seem to be 
a marked difference in the level of IgA in both treatment groups (Table-
13). 
After treatment upto 5 years the IgA values have been obtained 
always higher in over 2 years of treatment group and the values were 
significantly elevated in multibacillary diseased group (LL & BL) having 
treatment upto 5 years than to 2 years treated group (Table 13). 
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DISCUSSION 
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There seem to be several discrepancies in the result of serum 
immunoglobulins level in leprosy (Bergot e^ al^. , 1963; Lim and Fusaro, 
1968; Bullock et^ al^. , 1970; Srisinha et_ al_. , 1972; Srivastava et^  a l . , 
1975; Youngchaiyud et_ a]_., 1975 and Petchclai et_ aj_. , 1977). But overall 
increase have been noted in the level of IgG and is also much expected 
as the antibodies to bacterial infections are present in IgG immunoproteins 
(Fahey, 1965; Merler & Rosen, 1966). 
It is a general concept that IgM is the first Imunoglobulins 
to become significantly elevated in an acute infection, (Merler & Rosen, 
1966). Since i t has been reported to be elevated in leprosy which is 
a chronic insidious disease , which may be probably due to various anti-
genic substances from the bacillus and as a resul t of reaction to the 
tissues (Olmos and Bonatti, 1951; Estrada ^ al.. . 1966; Merler and Rosen, 
1966). The other possible explanation for the elevated IgM levels especia-
lly in the lepromatous types of leprosy is the continuous multiplication 
of leprosy bacillus and the resulting reaction of the host tissue to the 
large population of the bacter ia . 
Our findings indicate that levels of IgM proteins have shown 
slight increase, over controls and i t s significant increase as reported 
in early infections in leprosy does not seem to correlate with previous 
findings. Since the study has been conducted on cases already having 
full blown symptoms. The slow insiduous progress of the disease is so 
smouldring that e i ther i t may not be increasing in clinically detected 
cases or i ts presence may only be detected in very very early forms. 
The pattern of immtinoglobulins with respect to age does not 
seem to have any bearing since no variation could be recorded. Extreme 
polar variation in immunoglobulins protein is significant but interpolar 
values are not of much differentiations. 
Among the unusual protein abnromalities secondary macroglobu-
linemia occurred most frequently. This seems peculiar to lepromatous 
leprosy, since it was not found in Tuberculoid cases . The serological 
pattern was very similar to that observed in some cases of rheumatoid 
a r th r i t i s and l iver c i r rhos i s , (Pinto et a l . , 1964). 
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The treatment of patients for considerably longer period does 
seem to play some role and there is definite increase in the level of 
IgG in TT and decrease in LL pat ients . 
The explanation for these variable changes largely remains obscure 
and correlation of the immunoglobulins changes with leprosy variable is 
difficult, but the possible decrease of the level of IgG antibodies in LL 
cases after prolonged treatment seem to have a direct link with the de-
crease in the antigenic load due to prolonged treatment, which lessens 
the number of bacteria due to stoppage of multiplication of the bacil l i , 
but our result shows a decreased value in serum IgG proteins in all forms 
of leprosy which is remarkably high in LL cases . Serum IgM in LF (LL 
& BL) have been documented to have significantly decreased values after 
prolonged treatment while serum IgA have increased significantly after 
treatment (Bullock et_ al^., 1970). 
our present results coincide with the resul ts of Bullock et_ al_. 
(1970) who had t r ied to correlate serum immunoglobulins level with treatment. 
There has been more controversy in the resul t of serum immuno-
globulins in NLF (BE, BL & LL) type of leprosy. Increased levels have 
been observed for IgG and IgA by Lim and Fusaro, (1968); Srisinha et^  
a l . (1972); Srivastava et_ al_. (1975) and IgM and IgD, Srisinha et^  al^ . 
(1972); Srivastava et^  al_. (1975) antibodies, whereas serum IgG and IgA 
and IgM in NLF were found to be normal by Bullock et^  al_. (1970) and 
Youngchaiyud et^ ail_. (1975), while Lim and Fusaro (1968) found only serum 
IgM to be normal in NLF. Our findings among NLF are contrary to Lim 
and Fusaro (1968); Srisinha et^  al_. (1972) and Srivastava et^  al_. (1975). 
In our study serum IgM protein has been found to decrease after prolonged 
treatment. 
Present day cr i ter ian for classification of leprosy includes clinical 
manifestations, presence or absence of M. leprae in the lesions, characteri-
stic pathology and lepromin test ing. 
If immunoglobulin patterns present in the sera samples of these 
leprosy patients is included i t may provide an adjunct to the basis of 
classifiation of leprosy which has also been suggested by Ridley and Jop-
ling (1966). 
SUMMARY 
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Serum immunoglobulins were estimated by single radial immuno-
diffusion technique and results were compared among various groups of 
leprosy patients having treatment 6 months to 5 years with DDS. 
Most of the serum immunoglobulins classes are increased in leprosy 
patients against control groups. But a marked decrease serum IgG, IgM 
and increase in IgA was found in patients treated with 2 to 5 years with 
DDS when compared with group treated 6 months to 2 years with DDS. 
This can lead to different interpretations of resul t in leprosy patients 
and may explain apparent discrepancies in earl ier s tudies of serum immuno-
globulins in l eprosy . 
TOTAL SERUM PROTEIN AND ALBUMIN GLOBULIN RATIO 
REVIEW OF LITERATURE 
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Leprosy, besides being important as a serious cause of morbidity 
and mortality in underdeveloped countries, continues to produce social 
ostracism and fascinate the biologists . This is because of unique range 
of host-parasi te intractions between man and Mycobacterium leprae. One 
polar form of leprosy is characterized by high cellular immunity and 
res t r ic ted disease, whereas the other form shows absence of cellular 
immunity to the parasi te and paradoxically hyperreact iv i ty of the humoral 
immune system to all antigens (Almeida, 1970). A study of the chemistry 
of tissues and physiological fluids may help to understand the pathophysio-
logy of the disease . Leprosy is known to have disequilibrium of serum 
proteins with al terat ions in serum albumin and globulin fractions. Dhople 
and Magar (1963), Sehgal (1968), Kapoor et_ al^. (1971) and Gupta et^  £1.. 
(1978a) have reported changes in the serum proteins in different types 
of leprosy but the resul ts are at variance to each o ther . 
The ear l ies t biochemical changes observed in leprosy was the 
deviation in the plasma proteins . The serum protein abnormalities were 
more pronounced in the advanced cases and tended to rever t towards nor-
malities as clinical improvement occurred. Earlier workers (Wade, 1926; 
Greval 1927; Greval et^  al_. , 1939) have shown that there is alteration 
in the serum albumin and serum globulin rat io in the blood of the leprosy 
patients . 
Ishihara (1953a) reported that the concentration of serum proteins 
in leprosy patients evidently increases in far advanced lepromatous leprosy, 
but not in other forms of the disease . 
On fractioning the serum or plasma proteins of leprosy patients 
cases of the maculoneural forms yield essential ly the same results as 
do normal healthy persons, whereas in lepromatous form there is a de-
crease of albumin and increase of globulin portion. 
The fractionation in cases of ENL resembles those of far advanced 
lepromatous leprosy , with a decrease of albumin and increase of gamma 
globulin. Alter the subsidence ot the reaction the gamma globulin decrea-
ses and the albumin increases. 
Gamma globulin plays an important role in the acceleration ot 
blood sedimentation in cases of leprosy. 
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Pozzo and Felicitas (1955) reported that the biochemical altera-
tions in the intermediate (dimorphous), group were variable to a consi-
derable extent. 
Bonnati and Lebron (1958) reported s l ight ly higher values of 
gamma-globulin in the sera of patients with dimorphous type of leprosy. 
Other globulin fractions were scarcely al tered in their ser ies , though 
the decrease in the relat ive percentage of albumin in dimorphous type 
of leprosy was found to be highly significant (p •^0.0001) . The alteration 
in the absolute amount of albumin was not found to be significant. 
Muelling et^ al_. (1960) studied the sera from patients with active 
and inactive tuberculoid lesions and noted sl ight increased levels of total 
proteins. They found elevated levels of both beta and gamma globulin 
fractions and that the increase in beta-globulin was more marked than 
gamma-globulin. Albumin remained normal and the alpha globulin fraction 
showed elevation only in occasional cases . 
Bideau (1960) studied 20 cases of dimorphous type of leprosy 
and found no dysproteinaemia. 
Jordin and Beytout (1960) at tr ibuted the increase in gamma frac-
tion in leprosy patients to a decrease of the other fractions like albumin, 
alpha and beta-globulins. They suggested that other changes in serum 
proteins pattern some times found in leprosy patients (alpha and beta-
globulins gluco and l ipoproteins) were not a t t r ibutable to leprosy itself, 
but were due to secondary and concomitant afflictions like tuberculosis, 
nephri t is or nephrosis and amyloidosis in par t icular . 
Controw Trumper (1962) reported increased alpha globulins frac-
tion which commonly occurs in a great var ie ty of conditions accompanied 
by inflammatory or destructive lesions, acute and chronic infections. The 
exact mechanism for this increase is not c lear . However, mucoproteins, 
contained in this fractions may be of significance in th is connection, which 
points towards excessive tissue damage. 
Dhople and Magar (1963) noted a decrease in alpha-globulin 
and an increase in beta globulin in non-lepromatous type of leprosy. They 
studied the re la t ive percentage of different fractions of serum proteins 
but did not calculate the absolute values. Nudenberg (1965) produced 
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evidences that the hyper-gamma globulinaemia in cases of indeterminate 
type could be an indication of pre-lepromatous character . Thomas and 
Anantchari (1966) studied serum proteins in the cases of tuberculoid lep-
rosy and noted slight increase in beta globulin fraction only. 
In lepromatous leprosy besides severe hypergamma-globulinaemia 
with low albumin and hyper alpha-2-globulinaemia the increase of all 
three immunoglobulins and of heptoglobin was observed by Bonomo et^  al_. 
(1969). In tuberculoid leprosy serum protein changes were definitely less 
conspicuous, in contrast to the status in lepromatous leprosy. IgA and 
IgM fractions were almost never increased. The pat tern of serum protein 
of ENL appeared very similar to that of lepromatous leprosy. As compared 
with this form, however, lower immunoglobulin values were detected in 
upgrading form of leprosy. Paraproteinaemia was found in three cases 
and in four other cases hypogammaglobulinaemia occurred. 
Kapoor et a l . (1971) reported that in tuberculoid leprosy, elec-
trophoretic studies of the sera showed a highly significant increase in 
total protein and gamma globulins. No significant al terations was observed 
in albumin, a l p h a - 1 , a lpha-2 , and beta-globulins. The increase in total 
serum proteins was pr imari ly due to an increase in the gamma globulin 
fraction. Similar resu l t s have been reported by Chakarvart i (1951) and 
Pozzo and Folicitas (1955). 
In dimorphous leprosy , Kapoor et^  a l . (1971) observed a signifi-
cant increase in total protein and gamma globulin and a decrease in alpha-1 
globulin. Alteration in albumin, alpha-2-globulin and beta-globulin were 
not significant. In lepromatous leprosy the increase in total protein and 
all the different globulin fractions and a consistent decrease in the albu-
min fraction were found to be s ta t is t ical ly highly significant. Studies 
of relat ive percentage of different fractions of globulins were found to 
have increase in gamma globulin fraction. Similar resul ts were obtained 
by Miguel et_ a]_. (1954), Mauze and Arnaud (1954), Pozzo and Felicitas 
(1955), Richardo et_ al_. (1958), Bonnati and Lebron (1958). 
Gupta et^ a\_. (1976) tested 20 lepromatous leprosy patients sera 
and detected an additional protein band between beta and gamma globulin 
fractions in 3 cases . They described it as an abnormal band and attributed 
the hyperglobulinaemia and the presence of the abnormal band to over 
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activi ty of the reticuloendothelial system. The gamma-globulin showed 
an increase of 56.16% in lepromatous leprosy and 60.72% in lepra reaction 
group. The r i s e in gamma globulin fraction in both the groups were sta-
t is t ical ly highly significant. The resul ts are in agreement with the obser-
vation reported by most of the workers v iz . Balakrishnan (1965), Thomas 
and Anantchari (1966), Sehgal (1968), Kapoor et^  £l^. (1971), Mukherjee 
and Ghosh (1973), Gupta et_ al_. (1976), Gupta et^  al_. (1978a) and Venka-
tesan and Bhardwaj (1978). 
Gharpuray et_ al_. (1977) have reported that the abnormalities 
were reversal of the albumin/globulin rat io in lepromatous (all reactional), 
tuberculoid and dimorphic cases of leprosy and an increase in beta-glo-
bulin fraction in the lepromatous group, but total proteins were within 
normal l imits . 
Gupta et_ a l . (1978a), however, observed a significant increase 
of all the immunoglobulins, IgA, IgM, IgG in lepromatous leprosy which 
indicated a humoral response which was found direct ly proportional to 
the severi ty of the disease . 
The contention of Cochrane (1959) points out that greater the 
amount of the circulating antibodies the less able are the tissues to defend 
themselves against Mycobacterium leprae . 
Kumar et^  a l . (1982) observed that total serum proteins were 
sl ightly lowered in BB, BL and LL patients , and total albumin was low 
in all types of leprosy especially in the BL group. Alpha-1 and alpha-2 
fractions were unchanged all through the leprosy spectrum. Beta-globulin 
were significantly lowered in LL patients as compared to the controls. 
Gamma-globulins were elevated in all types of leprosy more so in BB, 
BL and LL pat ients . 
Baji et^  a l . (1982) observed a significant increase in serum total 
proteins in lepromatous leprosy and in lepra reactions. The r ise was 
s ta t is t ical ly highly significant as compared with the controls. 
A decreased level of serum albumin was tound in both lepromatous 
leprosy and lepra reactions with a concomitant r i se in globulin resulting 
in reversal of A/G rat io (Baji et_ al_. , 1982). 
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Albumin synthesis takes place exclusively in hepatic cells where-
as globulin synthesis occurs both in plasma cells and lymphocytes. There-
fore, one or more factors l ike decreased albumin synthesis due to hepatic 
dysfunction and/or increased synthesis of globulin due to stimulation of 
reticuloendothelial system, might be responsible for the lowering of serum 
albumin and increase of serum globulin. It may be pointed out that de-
creased serum albumin level is associated with oedema that leprosy patient 
display (Baji et a l . , 1982). 
MATERIALS AND METHODS 
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CHEMICALS 
All t h e c h e m i c a l s u s e d d u r i n g p r e s e n t s t u d y w e r e of h i g h e s t 
p u r i t y of AR/GR g r a d e s , s u p p l i e d b y s t a n d a r d c h e m i c a l f i r m s . 
SERUM SAMPLES 
A t o t a l of 64 s e r a s a m p l e s w e r e o b t a i n e d f rom l e p r o s y p a t i e n t s 
h a v i n g d i f f e r e n t g r a d e s of l e p r o s y c l a s s i f i e d a c c o r d i n g to R i d l e y Jop l ing 
S c a l e ( 1 9 6 6 ) . T h e s e i n c l u d e d 14 s e r a s a m p l e s of T T , 15 BT, 16 BL and 
19 LL c a s e s . B e s i d e s p a t i e n t s e r a , 10 s a m p l e s w e r e c o l l e c t e d f rom a p p a -
r e n t l y n o r m a l h e a l t h y i n d i v i d u a l s h a v i n g no f a m i l i a l h i s t o r y of l e p r o s y 
fo r c o n t r o l p u r p o s e a n d 12 c l i n i c a l p a t i e n t s of t u b e r c u l o s i s w i t h sputum 
p o s i t i v e s m e a r s fo r a c i d f a s t b a c i l l i w e r e c o l l e c t e d f r o m B a l r a m p u r Hosp i -
t a l , L u c k n o w . 
C o l l e c t i o n s of b l o o d a n d s e p a r a t i o n of s e r u m h a s a l r e a d y been 
d e s c r i b e d e a r l i e r . 
TOTAL PROTIEN ESTIMATION 
T o t a l p r o t e i n w a s e s t i m a t e d a c c o r d i n g t o t h e m e t h o d of Lowry 
£t^ al_. (1951) u s i n g B o v i n e s e r u m a l b u m i n (BSA) a s s t a n d a r d . 
STOCK SOLUTIONS 
So lut ion (A) 
A l k a l i n e s o d i u m c a r b o n a t e s o l u t i o n 
NaOH 0 . 4 gm 
Na-CO 2 . 0 gm 
D i s t i l l e d w a t e r 100 ml 
Solut ion (B) 
C o p p e r s u l p h a t e s o l u t i o n 
CuSO . 5H O 0 . 5 gm 
N a - K - T a r t a r a t e 1.0 gm 
D i s t i l l e d w a t e r 100 ml 
WORKING ALKALINE COPPER SULPHATE SOLUTION 
F o u r t y n i n e ml ot a l k a l i n e s o d i u m c a r b o n a t e s o l u t i o n w a s m i x e d wi th 
ml. ot CuSO^ 4 
j u s t b e t o r e u s e . 
1 l. t  s o l u t i o n . T h e w o r k i n g s o l u t i o n w a s a l w a y s p r e p a r e d f r e sh 
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FOLIN-CIOCALTEAU'S PHENOL 
Folin-ciocalteau's phenol was obtained from SISCO Research Labo-
ratory Pvt. L t d . , Bombay as 2N solution. This was diluted up to IN 
with dis t i l led water for use in protein estimation and stored at 4°C. 
TEST SYSTEM 
0.1 ml optimally diluted test sample and 0.1 ml standard solution 
(IS BSA) were mixed thoroughly with 5 ml of freshly prepared alkaline 
copper sulphate solution in separate tubes and allowed to stand at room 
temperature for 10 minutes. 0.5 ml of IN Folin-Ciocalteau's Phenol reagent 
was added rap id ly in each tube with immediate mixing. 
Reactions was allowed to continue upto 30 minutes at 37°C and 
then optical densit ies were recorded at 625 nm using spectronic 20(R) 
spectrophotometer (Bausch and Lomb). 
SERUM PROTEIN ELECTROPHORESIS 
Serum protein electrophoresis was carr ied out according to the 
method described by Beckman microzone electrophoresis manual by Jane 
M. Peck (1979). 
1. Buffer 
Barbital barbi tur ic acid buffer was used for electrophoresis 
of serum prote ins . This was supplied by Beckman Instrument Inc . , as 
B-2 Buffer pH 8.6, molarity 0.075 m. The content of one packet was disso-
lved in one l i t r e volumetric flask and diluted to the mark. The buffer 
was dissolved in about half an hour in warm water. The buffer was stored 
in a refrigerator at 4°C but was brought to room temperature before use. 
2. Fixative-Dye solution 
For staining the protein bands Ponceau's fixative dye solution supplied 
by Beckman Instrument Inc. was used. 
The content of one packet was diluted to 250 ml with distil led 
water. The staining solution may be used a number of time provided it 
is stored in closed bottles at 4''C. 
The re la t ive concentration of the components of fixative dye 
solution in d is t i l led water were as follows:-
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0.2% Ponceau ' s s ta in (W/V) 
3.0% T r i c h l o r o a c e t i c ac id (W/V) 
3.0% Sul fosa l icy l ic ac id (W/V) 
3 . Rinse solution 
5% g lac ia l a ce t i c ac id ( v / v ) was used for r ins ing the cel lulose 
ace ta te membrane s t r i p s . 
Glacial ace t i c ac id 5 ml 
D i s t i l l e d wa te r 95 ml 
4. Dehydration solution 
Dehydra t ion of the ce l lu lose ace t a t e membrane s t r i p was perfor-
med using full s t r eng th e t h y l a l c o h o l . 
5. Clearing solution 
25% g lac ia l ace t i c ac id in t h e full s t r egn th e thy l alcohol was 
used for c l ea r ing t h e s t r i p s . 
Glacial a c e t i c ac id 25 ml 
E thy l a lcohol 75 ml 
APPARATUS 
E l e c t r o p h o r e s i s a p p a r a t u s (Beckman R-lOO Apparatus) suppl ied 
by Beckman Ins t rument I n c . was u sed . 
Major components of t h i s a p p a r a t u s w e r e : 
a. E l e c t r o p h o r e s i s ce l l (Cat No.R-101) 
b . Duostat Power Supply (R-120) 
c . Scanning Densi tometer (R-112) 
Samples on the ce l lu lose membrane were a p p l i e d with the help 
of Beckman Microzone A p p l i c a t o r . 
PROCEDURE 
Reconst i tu ted B-2 buffer was poured into both the ha lves of 
e l e c t r o p h o r e s i s ce l l such tha t t he l eve l on e i t h e r s i d e was approximately 
at the lower l eve l l i n e . About 230 ml ot buffer was r e q u i r e d to f i l l the 
cel l to the p r o p e r l e v e l . 
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After saturating the cellulose acetate membrane with B-2 buffer' 
it was mounted on membrane bridge assembly with the free ends of the 
membrane pointing downward. Now the membrane assembly was placed 
in the ce l l . Serum sample was applied for 5 to 7 seconds on buffer satu-
rated membrane with the help of Beckman appl icator . Electrophoresis 
was performed for 16 to 18 minutes at constant power of 250 volts current 
which tended to increase from 4 to 6 milliampere during the entire 
period. After e lec t rophores is , the membrane was stained for 7 to 10 minutes 
in fixative dye solution, rinsed with three successive washes in 5% acetic 
acid and dehydrated in absolute alcohol for 5 minutes. A clean glass 
plate was placed into the clearing solution and dehydrated membrane was 
placed on th is glass plate and agitated for 5-6 minutes. 
After clearing, the membrane on glass plate was taken out and 
allowed to a i r d ry . After drying the membrane was peeled off from the 
glass plate and kept in a plastic cover. Now it was ready for scanning. 
SCANNING 
Initial s l i t width was adjusted at 0.2 and neutral density filter 
at 1.4 cal , so as to obained appropriate graph for the standard reference. 
Now the envelop containing the membrane was placed on scanning carriage 
and pattern was obtained. 
RESULTS 
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All the 12 frank cases of tuberculosis included in the study 
were males between the age group of 28 to 65 years , kept on INH, Pyra-
zinamide and Rifampicin therapy ranging from 7 days to 5 months. Out 
of the 64 cases of leprosy 14 (2 female + 12 males) belonged to the tuber-
culoid group in which duration of the disease varied from 7 months to 
4 years . Five of the patients were kept on Dapsone monotherapy and 
the res t on Dapsone + Rifampicin multidrug the rapy . Fifteen cases (2 
female + 13 males) were of Borderline tuberculoid types in which the 
duration of the disease ranged between 2 to 10 years . Two of them were 
fresh cases to the clinic without any previous treatment, rest of them 
were receiving Dapsone monodrug therapy . 
A total of 16 males were in borderl ine lepromatous groop and 
19 belonged to lepromatous group having duration of the disease ranging 
from 3 to 18 years receiving DDS monotherapy from 9 months to 14 years. 
The electrophoretic patterns of serum proteins and their ratio 
along with total estimations of tuberculosis cases i s presented in the 
table 14 and 15. 
In overall view, there is a considerable increase in the total 
serum proteins in diseased cases over the normal controls. The albumin 
percentage has lower values in diseased cases but the globulin fraction 
par t icular ly the gamma fraction has been found to be much more elevated 
over controls. 
The total percentage of albumin and globulin in the semm and 
their ra t io in leprosy patients has been presented in Table 15. When 
compared to controls the total serum proteins have elevated values in 
all cases of leprosy r ight from one Polar end (TT) to the other Polar 
end (LL). 
In our observations TT patients had the highest protein value 
(138.02 mg/ml) than any other form of leprosy, and there is a gradual 
decline in total serum protein values when the spectrum moves from TT 
to LL s ide . 
Percent of albumin in the leprosy patients sera has not shown 
any definite pattern but in almost all torms (except BT cases) there is 
decline in values over controls and a significant decline of albumin value 
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in LL cases where it has gone down to 22,17%. 
The total globulin percentage in all forms of leprosy has gone 
significantly h igh, but the percentage of various fractions like alpha-
1, alpha-2 and beta have normally not shown much of variation than the 
controls. The value of gamma globulins have significantly risen over the 
control values and a minimum of at least two fold increase in each case 
is obvious. 
Enough variations has not been seen in the values of gamma 
globulins of different forms of leprosy but the highest value of 42.85% 
has been recorded in BL pat ients . The A/G rat io recorded in the LL 
patients sera has shown minimum value of 0.43, since the albumin values 
in these patients was found to be very low. 
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Fig.8: Showing Electrophoretogram of normal healthy sera . 
Fig.9: Showing Electrophoretogram of Tuberculosis (TB) Patient sera. 
Fig.10: Showing Electrophoretogram of Tuberculoid (TT) leprosy 
patient sera . 
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Fig.11: Showing Electrophoretogram of Border line Tuberculoid (BT) 
leprosy patient se ra . 
Fig.12: Showing Electrophoretogram of Border line Lepromatous (BL) 
leprosy patient s e ra . 
Fig.13: Showing Electrophoretogram of Lepromatous (LL) 
leprosy patient se ra . 
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DISCUSSION 
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There is an unique type of host -paras i te interaction between 
man and M, l eprae , depicted by wide range of variations in the complete 
spectrum of leprosy. This leads to variation in the immunological status 
and variat ions in the bioconstituents of the t issues and body fluids of 
various grades of leprosy pat ients . 
In advanced cases of lepromatous leprosy total serum proteins 
were found to be higher than normal (Almeida, 1970; Sern et^  al_., 1974 
and Gupta et_ al_. , 1978a). Dysproteinaemia associated with hypergammaglobu-
linaemia and pers is tent var iable increased levels in lepromatous leprosy 
remains an intriguing problem (Bideau, 1960; Turk and Bryceson, 1971). 
Malaviya et_ al_. (1972) did not find s ta t is t ical ly significant diff-
erence between levels of immunoglobulins in the sera of LL patients and 
controls. Hypergammaglobulinaemia is supposed to be responsible for the 
r i se in serum prote ins . Increase in total serum proteins in leprosy par t i -
cularly more marked in LL patients has been observed and was explained 
by the proportionate increase in gamma globulin level . 
Other workers (Bideau 1960; Jordin and Beytout 1960) did not 
find dysproteinaemia in tuberculoid leprosy, whereas Gupta et^  al^ . (1978a) 
found decrease level of total serum proteins in all forms of leprosy and 
more so in LL cases . Therefore, the amount of protein present in various 
grades of leprosy has been confusing and an answer to this problem is 
of much in te res t . The findings of the present study indicate that all diff-
erent grades of leprosy had elevated protein values than the controls 
which is in contrast to the results obtained in several studies but in 
agreement with that of Sern et^  al_. (1974), Gupta et^  al_. (1978a). 
Since the humoral immunity is ac t ive , although not protective 
in frank as well as hidden cases of tuberculosis hence a significant level 
of serum protein elevation is desirable and has been rightly obtained 
during the present investigation. 
Generally in all chronic infections there is a decrease in albumin 
and an increase in the globulin proportions. To contact the foreign "Antigen" 
there appears to be a diversion ot amino acids for synthesis ot immunoglo-
bulins in preference to that of albumin (Talwar 1980) hence globulins 
for exceed the values of albumins. 
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Albumin synthesis takes place exclusively in hepatic cel ls , where-' 
as globulin synthesis occurs both in plasma cells and lymphocytes. There-
fore one or more factors like decreased albumin synthesis due to hepatic 
dysfunction and/or increased synthesis of globulin due to stimulation of 
reticuloendothelial system, might be responsible for the lowering of serum 
albumin and increase in the serum globulins. It may be pointed out that 
decreased, serum albumin levels are associated with oedema that leprosy 
patient d isp lay . 
In our observation the albumin percentage has considerably de-
creased values in diseased cases but the globulin portion particularly 
the gamma fraction has been found to be highly elevated over controls. 
In humoral antibody responses serum albumin normal y remains 
at a constant level but the gamma globulins are much dispelled over the 
normal values and exceeds the value of albumin, since antibodies are 
normally gamma globulins, hence there has been a decrease in the A/G 
ratio of the diseased over controls. 
Low serum albumin has been reported in all types of leprosy 
(Muelling et_ al_., 1960; Gupta et^ al_. , 1978a; Gupta et_ al_., 1978b). The 
level of albumin was lower in all types of leprosy patients in the present 
study and a lower albumin value was also recorded in tuberculosis, 
but BT cases exhib i ted a higher value against Normal controls. The cause 
of low albumin values could perhaps be at tr ibuted to the chronic destruc-
tive nature of the disease and l iver involvement (Edington and Gilles, 
1976). Poor nutritional status may be an other aggravating factor in pro-
ducing hypoalbuminaemia. 
Our resul ts corroborates with the findings of (Muelling et_ a l . , 
1960; Gupta et^  al_. , 1978a; Gupta et^  al_. , 1978b) for all types of leprosy 
and is true for tuberculosis patients a lso . 
Alpha-1-globulins have been found to be normal (Muelling et_ 
a l . , 1960; Gupta et_ a]_. , 1978a; Gupta et^  al_., 1978b) but Dhople and Magar 
(1963) and Saoji et_ a]_. (1978), however, observed a decrease in alpha 
globulins values on nonlepromatous end of the spectrum. 
In our observations a considerable variation of alpha-1-globulin 
has been observed which is almost equal to normal control values which 
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again in agreement with the resul ts of Muelling et_ al^. (1960), Gupta et_ 
al_. (1978a) and Gupta et_ al_. (1978b). 
Alpha-2 globulins were found to be unchanged in borderline lep-
rosy but significantly decreased in BT and increased in LL patients (Gupta 
et a l . , 1978a). The value of alpha-2 globulins were found to be unchanged 
in all types of leprosy except in LL patients where decreased levels 
have been obtained against the controls. This finding is in agreement 
with that of Gupta et^  al_. {1978a) except in LL cases . 
Increased level of p-globulins in all types of leprosy have been 
observed regularly (Muelling et_ al_,, 1960; Dhople and Magar, 1963; Gupta 
et_al_. , 1978a). 
Jordin and Beytout (I960) observed a fall in beta-globulins level 
in various types of leprosy whereas Gupta et^  £1.. (1978a) observed a dec-
rease in BL and increase in BT patients which were s tat is t ical ly significant. 
In our observation an increased level has been recorded in TT, 
BT and tuberculosis patients while a decreased level was observed in 
LL and nearly equivalent to normal value was observed in BL patients 
sera which is contrary to the results of Jordin and Beytout (1960) but coin-
cides with the statement of Gupta et_ aj|_. (1978a). 
Rise in Gamma globulins was found in all types of leprosy, maxi-
mum in the lepromatous group of pat ients . This has been observed regularly 
(Muelling et_ al_. , 1960; Dhople and Magar, 1963; Sheagren et_ al_., 1969; 
Jha et_ al_. , 1971; Kapoor et_ al_. , 1971; Malaviya et^ al_., 1972; Saha and 
Mittal, 1972; Gharpury et_ al^., 1977; Kelkar et^ al^., 1979) in all studies. 
The increase in the gamma globulins may be due to the increased activity 
of B lymphocytes which are the precursors of antibody producing cells 
and are responsible for increased immunoglobulins in lepromatous leprosy. 
In our observation a significantly elevated level has been recor-
ded in almost all deseased leprosy cases as well as in tuberculosis pa-
t ien ts , and A/G rat io recorded in the LL patients sera has shown minimum 
value against all other diseased cases as well as controls since the albumin 
in those patients was found to be very low. 
SUMMARY 
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A comparison of total serum proteins , albumin and globulin ratio 
along with different fraction of globulins from the leprosy patient sera 
covering the entire spectrum (Ridley Jopling, 1966) and tuberculosis has 
been made. There has been a considerable increase of the overall total 
serum proteins of leprosy and tuberculosis patients over the normal con-
t ro l s . The albumin value has shown a decline over globulin value and 
the level of gamma globulins has indicated significant degree of elevation 
in leprosy patient sera indicating the outplay of humoral response. The 
A/G ratio in leprosy has shown a declining trend in values as the spectrum 
moves from TT to LL s ide . 
SERUM ENZYME PROFILE 
REVIEW OF LITERATURE 
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There has been increasing interest during recent years in the 
study of serum enzyme changes in leprosy pat ients . This disease involves 
multiple systems and several forms have been presented on the scale. 
(Riddley Joping, 1966), therefore, simultaneous determination of enzymes 
with other parameters may yield more information concerning the progress 
of the disease than isolated estimations, Bulakh et^  al_, (1982). 
De Duve and coworkers (1955) proposed the term "lysosomes" 
when they found a special group of particles in cytoplasm of rat l iver , 
and five dist inct acid hydrolases were sequestered within those lysosomes 
in muscular dys t rophy , (Weinstock et^  al^., 1958; Tappel et_ al_., 1962 and 
Zalkin et_ al_. , 1962). Very limited studies have been done in recent years 
on lysosomal enzymes in leprosy. Brieger and Allen (1962) have shown 
increased act ivi ty of the acid phosphatase in leprosy t issues . 
Palekar and Magar (1967) reported increased activi ty of four 
lysosomal enzymes v iz . acid phosphatase, cathepsin, ribonuclease and 
arylsulphatase in leprosy t issues . 
Job & Nadu (1970) reported an increased acid phosphatase activity 
of macrophages in tuberculoid and lepromatous leprosy. The activation 
and leakage of the enzymes from lysosomes are involved in some of the 
manifestations of the lepra reaction l ike auto-immune disorders , rheumatic 
a r t h r i t i s , sclerodermic lesions, direct comb's posit ive haemolytic anaemia 
e tc . Leakage from the damaged cells resulting in a spi l l over of the lyso-
somal enzymes into the circulation. 
The enzyme acid phosphatase, which provides a direct measures 
of lysosomal ac t iv i ty , has been demonstrated by histochemical techniques. 
This enzyme has been reported to be present in lepra cells (Breiger and 
Allen 1962). An increased act ivi ty of acid phosphatase was found in the 
l iver homogenate of mice infected with M. lepraemurium, (Mathur et_ al . , 
1969). Acid hydrolases were reported to be present in host liver and 
their ac t iv i t ies were elevated in l ivers infected with M. leprae. An obser-
vation consistent with the enhancement of act ivi t ies of lysosomal hydrolases 
in infected macrophages, (Karnovsky e^ a l . , 1975). It was, therefore, 
essential to establ ish that acid hydrolases in extract ot M. leprae were 
authentic bacterial enzymes which is present at re lat ively low activities 
in M. . leprae. Acid phosphatase act ivi ty in extracts from surface treated 
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M. leprae by NaOH was present at 0.3 - 0.6% of the level detected from 
M. avium, (Andrejew, 1968), M. phlel and M. microti . 
The changes in phosphatase act ivi ty in advanced cases of leprosy, 
possibly due to disturbed power to hydrolyse phosphate ester by plasma 
was reported by Villela (1938); Patterson, (1959) reported a continuous 
slow diffusion of phosphatase above normal rate in those patients of leprosy 
who showed specific destructive bony lesions. 
Dhople and Magar (1962) have observed gradual increase in phos-
phatase ac t iv i ty with the sever i ty of the disease in various types of 
leprosy though the values for alkaline phosphatase were within normal 
l imits . 
Bulakh et^ al_. (1982) reported that serum alkaline phosphatase 
act ivi ty was observed to be on the higher side of the normal range in 
Tuberculoid leprosy. Dhople and Magar (1962); Ramu and Nagarajan (1962); 
Mukherjee and Ghosh (1973); Kapoor and Gupta (1974); have reported the 
alkaline phosphatase act ivi ty in different types of leprosy. They have 
consistently found the enzymatic act ivi ty within normal range. Contrary 
to t h i s , I sh iha ra , (1953b); Mukherjee and Ghosh, (1973) have reported 
that in all types of leprosy v iz . dimorphous, lepromatous and lepra reac-
tion, the values of serum alkaline phosphatase were always found to be 
elevated than the normal range. 
Venkatasubramanium (1941) noted a definite increase in values 
of serum alkaline phosphatase in presence of leprotic lesions in bones. 
Serum transaminases SCOT & SGPT are concentrated mainly in heart 
muscle and l iver but they are also found in skeletal muscles, pancreas, 
kidney and b ra ins . Liver is the r iches t source of transaminases next to 
cardiac muscles. In l iver diseases large quantities of transaminases enter 
into the blood stream (De Ritis e^ £l.. . 1956; Madsen et^  £l_. , 1957; Molander 
et^al^. , 1957; Wroblewski, 1959). 
The serum transaminases levels may be raised in various clinical 
conditions involving damage of heart muscles, (LA, Due e^ al_. , 1954) and 
in various types of hepatic d i so rders , (Molander et_ al_. , 1957) and in 
myopathies (Libermann £t_ aj_. , 1957) and it is stated that hepatic cirrhosis 
cause moderate increase in both transaminases. The values are higher in 
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decompensated than in compensated form of c i r rhos i s . The relative rise 
in SGPT in lepromatous leprosy, indicating a toxic effect of leprosy bacilli 
on the hepatic cells and the r i se in SGPT is a more sensitive index of 
hepatic involvement in leprosy than the routine l iver function tests , (Shivde 
and Junakar, 1967). Acute hepat i t is is known to cause more r ise in SGPT 
than in SGOT, (De, Ritis et_ jal_., 1956); whereas c i r rhos is of liver causes 
moderate r ise in both transaminases, (Wroblewski, 1959). 
Lactate dehydrogenase is a zinc containing enzyme. It is an intracellular 
enzyme involved in glycolytic cycle . It is ubiquitously distributed in animal 
ce l l s . It is found in all body t issues and large amounts are found in mu-
sc les , hear t , l iver and kidney, (Wroblewski and Gregory 1961). Organ 
injury results in the release of LDH into blood. Elevated serum levels 
of LDH are useful as indicator of organ injury unless combined with other 
indices. 
Leprosy is a chronic infectious disease affecting many organs. 
Earlier work (Saito, 1972; Balakrishnan, 1976; Levitch & Novolkar, 1979' 
have revealed the importance of serum LDH and i ts enzymes in leprosy. 
In progressive cases of lepromatous type the var iab i l i ty of the total acti-
vity in the serum was remarkable and the LDH act ivi ty in one case in-
creased to 2-fold enzyme compared with control serum, (Saito, 1972). 
If the close correlation is present between the serum total LDH activity 
and the damaged tissues by lepra bac i l l i . Such var iabi l i ty of the serum 
LDH act iv i ty and isoenzyme pattern as observed in progressive cases might 
be considered to be reflected in several status of leprosy patients. 
Elevation in the serum lactic dehydrogenase have been noticed 
in the react ive phase of lepromatous leprosy (Balakrishnan, 1976) and 
tissue damaging effect of lepra bacil l i seem to play a part in its release. 
MATERIALS AND METHODS 
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CHEMICALS USED 
Na-pyruva t e and NADH (Nicot inamide adenine dinucleot ide reduced) 
were obtained- from SISCO Research L a b o r a t o r i e s Pv t . L t d . , Bombay ( Ind i a ) . 
DL-Alanine, c?C-Ketoglutaric ac id and DL-aspa ra t i c ac id were purchased from 
SIGMA Chemica l s . Pur i f ied ma te r i a l s of AR/GR Grades were used throughout 
t h e s t u d y . 
SERUM 
Five ml of venous blood was drawn a s c e p t i c a l l y from each pat ient 
having v a r i o u s g rades of l e p r o s y th rough t h e c o u r t e s y of Mission Leprosy 
H o s p i t a l , B a r a b a n k i . Blood samples w e r e k e p t a t STC for 2 hr and then 
at 4°C ove rn igh t so as to ob ta in maximum quan t i ty of serum which was 
co l lec ted in 0.1 ml a l l q u o t e s . The s t u d y inc luded a to ta l of 80 sera sam-
p les co l l ec ted from pa t i en t s having v a r i o u s g rades of l ep rosy according 
to Rid ley-Jop l ing (1966) s c a l e . The pa t i en t s had DDS treatment for per iods 
ranging from 6 months to 5 y e a r s a t t end ing t h e Mission Leprosy Hospi tal , 
B a r a b a n k i . Cases having h i s t o r y of d i a b e t e s m e l l i t u s , infective h e p a t i t i s , 
a l coho l i c h e p a t i t i s and malar ia were not inc luded in t h e s tudy . Samples 
compr i sed of s e r a obta ined from 25 a p p a r e n t l y h e a l t h y individuals all 
of whom were males ranging between t h e age group of 18 to 65 y e a r s . 
ESTIMATION OF ENZYMES IN SERUM 
The Enzyme l ac t i c dehydrogenase (LDH), ac id and a lkal ine phos-
p h a t a s e , serum glutamate oxa la t e t r ansaminase (SCOT) and serum glutamate 
p y r u v a t e t r ansaminase (SGPT) were s tud i ed using t h e method of Wooten 
(1964) . 
I . LACTIC DEHYDROGENASE (LDH) (Tota l ) 
Reagents 
( i ) Phospha te buffer (pH 7.4) 
Anhydrous Na.HPQ, - 11.30 gms. 2 4 
KH^PO^ - 2 .70 gms. 
Disso lve in 1000 ml of d i s t i l l e d water and adjust the pH to 7.4 
(wi th latandard bufter used tor the p u r p o s e ) . 
( i i ) Stock so lu t ion p y r u v a t e (Stock solu t ion) 
415 mg ot Na-pyruva te was d i s s o l v e d in 100 ml of phosphate 
buffer (pH 7.4) and kep t in tractions, a t -20°C until ut>e. 
( i i i ) Working pyruvate solut ion 
Stock p y r u v a t e solut ion d i l u t e d to 1:50 wi th phosphate buffer 
was u s e d , p r e p a r e d f r e s h l y e v e r y t i m e . 
( i v ) NADH (Nicotinamide Adenine d inuc leo t ide r e d u c e d ) 
Solu t ion : - 10 mg of NADH in 1 ml of p h o s p h a t e buffer was pre-
p a r e d a f resh for u s e . 
(v ) 2 , 4 , DNPH ( 2 , 4 , D i n i t r o p h e n y l h y d r a z i n e ) colour reagent (2mM): 4t9 
mg DNPH was d i s s o l v e d in 85 ml of cone. HCl and t h e volume was made 
upto 1000 ml wi th d i s t i l l e d water and s t o r e d in an ambour coloured bot t le . 
( v i ) 0.4N NaOH : - NaOH in 16 gm q u a n t i t y was d i s s o l v e d in 1000 ml of 
d i s t i l l e d water and s to r ed in d a r k p l a c e . 
All o t h e r reagents were p r e p a r e d using s t a n d a r d techniques . 
PRCX:EDURE 
Test 
(T) 
1 ml buffered 
s u b s t r a t e 
(d i lu t ed Stock so ln . ) 
0 .1 ml serum 
+ 
0.1 ml NADH so ln . 
Control 
(C) 
1 ml s u b s t r a t e + 0.2 ml 
buffer 
Blank 
(B) 
1.2 ml buffer 
Incubate at 37°C for 15 minutes 
1 ml. of DNPH solut ion was a d d e d to each tube a f t e r the specified 
incubat ion p e r i o d 
Shake well to mix and al low t h e tubes to s tand for 20 mts. 
Added 10 ml of 0. 4N NaOH and mixed well to s top the reaction 
Read the op t i ca l dens i ty (O.D.) at 510 nm. af ter 10 min. of the stoppage 
ot reac t ion using wa te r as r e f e r e n c e . 
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II . SCOT « SGPT 
(a) Common Reagents 
( i ) Phospha te b u f f e r : - Same as d e s c r i b e d e a r l i e r . 
( i i ) 2 , 4 - D i n i t r o p h e n y l h y d r a z i n e ( 2 , 4 , DNPH) (1 mM) colour reagent . 
49.50 mg. 2 , 4 , DNPH + 25 ml. Cone. HCl 
d i s s o l v e 
Volume made upto 250 ml wi th d i s t i l l e d w a t e r ; keep in an ambour 
co loured b o t t l e . 
( i i i ) 0 . 4 N - NaOH:- NaOH 16 gm. quan t i t y was d i s s o l v e d in 1000 ml of 
d i s t i l l e d wa te r and s to red in d a r k cool p l a c e . 
{b ) SGOT-Substrate 
13.30 gm. DL-aspa ra t i c ac id d i s s o l v e d in minimum quant i ty of IN-NaOH 
(4 gm. of NaOH in 100 ml d i s t i l l e d w a t e r ) . 
General ly 30 ml. IN - NaOH i s sufficient to d i s s o l v e the aspara t i c 
ac id by r e p e a t e d s t i r r i n g and shak ing (pH 7 . 4 ) . 
a d d e d 
cC-Ketoglutar ic ac id 0.146 gms. make t h e volume 500 ml with phosphate 
buffer (pH 7 , 4 ) . and 
s t o r e in an ambour coloured b o t t l e at 4°C. 
( c ) SGPT-Substrate 
DL-Alanine 9 gms. + 9 0 ml . d i s t i l l e d wa te r + 2 .5 ml. IN-NaOH 
Adjust pH to 7.4 
AddcC-Ketoglu tar ic ac id 0.146 gms, 
Make t h e volume upto 500 ml. wi th p h o s p h a t e buffer 
Again ad jus t t h e pH to 7.4 
Keep in a l iquo tes of 100 ml. and 250 ml. at -20°C. 
Avoid fungal g rowth , b r ing to room t e m p e r a t u r e before use. 
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(d) Standard pyruvate for SCOT & SGPT 
(Stock solut ion) 
Disso lve 220 mg of Sodium p y r u v a t e in 100 ml of phospha te buffer . 
Keep a t -20°C in f r a c t i o n s . 
(e ) Working pyruvate standard solution 
Stock solut ion of s t a n d a r d p y r u v a t e was d i l u t ed just before use . 
1 ml. of Stock + 4 ml of p h o s p h a t e buffer 
(1 :5 ) 
PRCX:EDURE FOR S(X)T 
Test 
(T) 
Control 
(C) 
S tandard 
(S) 
0.5 ml s u b s t r a t e 0.5 ml. s u b s t r a t e 0.1 ml working 
p y r u v a t e + 
+ 
0 .1 ml Serum 
0.4 ml s u b s t r a t e 
+ 0.1 ml d i s t i l l e d 
wa te r 
Blank 
(B) 
0.5 ml subs t ra t e 
+ 0.1 ml d i s t i -
l l ed water 
Incubate 
at ST^C for 60 minutes 
Add 
0.5 ml. of 2,4,DNPH immedia te ly af ter incuba t ion for 60 mts, 
Add 
0.1 ml of serum to only contro l t ubes 
Shake well and l eave for 20 minutes 
Add 
5 ml. of 0 .4 N-NaOH to t e s t cont ro l 
Blank and s t a n d a r d tubes 
Read 
O.D. at 510 m/u in B & L co lo r ime te r a t t e r 10 min. 
(Green t i l t e r ) using wa te r as r e f e r e n c e . 
a 
PROCEDURE FOR SGPT 
Test Control 
(T) (C) 
S tandard 
(S) 
Blank 
(B) 
0.5 ml s u b s t r a t e 0.5 ml . subs t r a t e 0 .1 ml working 
p y r u v a t e + 0.4 ml 
OPT s u b s t r a t e 
+ O.I ml D.W. 
0.5 ml subs t ra te 
+ 0.1 ml D.W. 
Incubate a t 37°C for 30 minutes 
Add 0.5 ml of 2 , 4 , DNPH immedia te ly a f te r 30 min. of incubation 
Then add 0.1 ml of serum to only contro l t ubes ; 
Shake well and keep for 20 minu tes . 
Add 
5 ml of 0.4 N-NaOH to s top t h e r eac t ion 
Read op t i ca l dens i ty ( C D . ) a t 510 mfi in B & L colorimeter after 
10 minutes (Green f i l t e r ) using wa te r as r e f e r e n c e . 
III . ACID PHOSPHATASE 
( i ) Reagents 
O.IN NaOH 0.4 gm of NaOH was d i s s o l v e d in 100 ml of 
d i s t i l l e d wa te r , 
( i i )Substrate 
0.41 gm c i t r i c a c i d , 1.125 gm sodium c i t r a t e and 165 mg Na-p-
n i t r o p h e n y l p h o s p h a t e d i s s o l v e d in 100 ml of Double Dist i l led 
w a t e r . 
PROCEDURE 
Test 
(T) 
Subs t ra t e 1.0 ml 
+ 0.1 ml serum 
Control 
(C) 
0.1 
only 
ml serum 
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Incubate at 37°C for 30 minutes , and af ter incuba t ion , add 10.0 ml of 
0.1 N NaOH to a l l t he tubes and af ter s topping t h e reac t ion , 1 ml. 
s u b s t r a t e was a d d e d to each contro l t u b e s . 
Read op t i ca l dens i ty at 420 mp using v i o l e t f i l t e r . 
IV. ALKALINE PHOSPHATASE 
( i ) Reagents 0.02N NaOH 0.08 gm NaOH was d issolved in 
100 ml of d i s t i l l e d wa te r . 
( i i ) S u b s t r a t e 
187.5 mg g lyc ine , 5 mg MgCl 6H O and 82,5 mg Na-p-n i t rophenyl 
p h o s p h a t e d i s s o l v e d in 21.0 ml of O.IN NaOH and d i lu ted to 50 ml. 
wi th double d i s t i l l e d water (DDW). 
PROCEDURE 
Test 
(T) 
Subs t r a t e 1.0 ml 
+ 
0.1 ml serum 
Control 
(C) 
0.1 ml serum only 
Incubate at 37°C for 30 minutes and af ter incuba t ion , add 10.0 ml of 
0.02 N-NaOH to a l l t u b e s , a f te r s topp ing t h e r eac t ion I.O ml of subs t ra t e 
was added to each control t u b e s . 
Read op t i ca l dens i ty a t 420 mp using v i o l e t f i l t e r . 
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SERUM GLUTAMATE OXALATE TRANSAMINASE (SCOT) 
The values of the enzyme SCOT have been presented in Table 
(16). It is obvious that there is increasing trend in values as the spec-
trum of the disease moves towards lepromatous pole. The only exception 
has been obtained with TT and BT patients sera . The TT patients sera 
have shown increased values but the BT sera samples have shown abrupt 
decline in values. BE, BL and LL patients sera have shown increabing 
values in the series indicating that th i s enzymatic pattern is directly 
proportional to downgrading of the disease spectrum. 
SERUM GLUTAMATE PYRUVATE TRANSAMINASE (SGPT) 
The enzymatic values of SGPT have been presented in Table 
(17). There has been cosistent increase in the values of this enzyme 
in patients sera , starting from BT to LL. But a steep decline in SGPT 
value was obtained in TT pat ients . The highest value of 24.17 ± 0.955 
was noted in LL patients whereas in TT patients sera the values dropped 
down to as low as 7.16 ± 0.235. 
SERUM LACTIC DEHYDROGENASE 
The variation in the level of lactic dehydrogenase seems to 
be of much significance because there is direct correlation of the increas-
ed enzymatic values with the downgrading lesions in leprosy patients. 
The TT patients have shown values which is almost equal to normal healthy 
controls. Borderline tuberculoids have also similar values as controls, 
but the LDH values have considerably increased in patients when the 
spectrum of the disease has moved towards BB, BL, and LL side. This 
is evident from the data presented in Table (18) where highest LDH 
value has been in LL pat ients ' sera . 
ACID PHOSPHATASE 
Serum acid phosphatase has shown a marked fluctuation in its 
specific act ivi ty in different types of leprosy against control value. 
In BB & BL, cases the specific ac t iv i ty ot serum acid phosphatase was 
significantly ra ised in comparison to control value. Similar observation, 
although a l i t t le lower, was found in TT cases (Table 19). The activity 
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of acid phosphatase when compared among the different grades of leprosy 
patients ranging from TT to LL, was found that LL patients has the lowest 
act ivi ty of th is enzyme (Table 19). 
ALKALINE PHOSPHATASE 
Serum alkaline phosphatase was found to have increasing trend 
when the spectrum of disease moved from TT (Tuberculoid) to LL (Lepro-
matous) type down-grading reactions. The data is presented in Table 
20, A significant degree of elevation has been recorded consistently in 
the specific act iv i ty of th is enzyme in BL patients compared to other 
forms of leprosy as well as controls . A considerable decrease in the 
value of th is enzyme was noted in TT patients when compared to normal 
controls. The concentration of th is enzyme seem to increase as the disease 
progresses towards LL pole, but the values are not so significant as 
to mark difference from control except in case of BL patients (Table 20). 
Table. 16: Enzyrm SGOT iavtl in tho. 6Q.n.u.m o^ VOAIOUA gA.adz6 o{, 
izpn.o6Lj patiznt^ and normal caAe.6. 
Cases of 
g rades of 
Nor 
TT 
BT 
BB 
BL 
LL 
dif ferent 
l e p r o s y 
mal 
No. of 
cases 
25 
14 
16 
16 
16 
18 
Enzyme l eve l 
in lU 
17.40 
15.95 
9.00 
13.37 
15.25 
33.91 
Standard 
devia t ion 
± 0.809 
± 0.915 
± 0.904 
± 0.908 
± 1.196 
± 2.53 
Table. 17: SeA.um S6PT £eve£ in VOAXOUA g^ade.^ oi 
lzpn.o^Lj patiznt-i) and nofimai ca-6e4. 
Cases of 
g r ades of 
d i f ferent 
l e p r o s y 
Normal 
TT 
BT 
BB 
BL 
LL 
No. of 
cases 
25 
15 
15 
15 
15 
15 
Enz ;yme leve l 
in lU 
12.25 
7.16 
13.41 
20.125 
21.20 
24.17 
Standard 
deviat ion 
± 1.360 
± 0.235 
± 1.37 
± 0.956 
± 1.70 
± 0.955 
Table. IS: Enzqmz LVH (Total) £eve£ in thz 6z^am oi vauouA QXadz^ o^ 
izp'to^Lj patiznti and non.mal ca^e-s. 
Cases of d i f ferent 
g rades of l e p r o s y 
Normal 
TT -
BT 
BB 
BL 
LL 
No. of 
cases 
20 
12 
14 
14 
16 
14 
Enzyme l eve l 
in lU 
190.735 
191.180 
191.680 
244.630 
246.310 
262.490 
Standard 
deviat ion 
± 1.129 
± 1 . 0 2 
± 1.04 
± 0.586 
± 0.666 
± 0.773 
Table. 19: Enzymt Acid pho6phata6Z lnvtl in thz i,tiam oi vanlouA gfiado.^ 
oi itpn.O'i>Lj paUz.nt6 and Non.mai ca6Z6. 
Cases of different No.of 
grades of leprosy cases 
Enzyme level in 
specific ac t iv i ty 
Standard deviation 
Normal 
TT 
BT 
BB 
BL 
LL 
20 
12 
12 
12 
12 
12 
4.46 
5.04 
4.81 
6.49 
5.77 
4.06 
X 10 
X 10 
X 10 
X 10 
X 10 
X 10 
-2 
-2 
-2 
i 4 .1 X 10 -3 
± 1.38 X 10 -2 
± 1.56 X 10 
± 4.2 X 10 
i 1.01 X 10 
-2 
± 9.5 X 10 -3 
Tabllj2. 20: Enzymz cdkcdim pho6phata6Z izvzi in tho. 'tOAixm oi voAiouA 
g^ad€6 o{, izpn.O'iitj patitnt^ and noimai caAt6. 
Cases of different No.of 
g r ades of l e p r o s y cases 
Enzyme l eve l in 
spec i f i c a c t i v i t y 
Standard deviat ion 
Normal 
TT 
BT 
BB 
BL 
LL 
20 
12 
12 
12 
12 
12 
41.43 X 10 
32.64 X 10 -2 
43.23 X 10 
48.10 X 10 -2 
61.29 X 10 -2 
44.20 X 10 -2 
± 5.2 X 10 -2 
± 7.02x 10 
± 5.7 x 10 
-2 
-2 
± 6.2 x 10 -2 
± 4 . 1 X 10 
± 9.9 X 10 -2 
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Since the f i rs t detailed descript ion of the pathology of leprosy 
hy Danielssen and Boeck in (1848) and Hansen and Looft in (1895), various 
workers have described lesions in the l iver of patients suffering from 
lepromatous leprosy. 
Liver involvement in tuberculoid leprosy was considered to be 
ra re until Arning (1936) first described the changes in the liver in that 
type of leprosy. 
Liver is the r ichest source of transaminases next to cardiac 
muscles. In l iver diseases large quantities of transaminases enter the blood 
(De Ritis et^  al_. , 1956; Madsen et^  al_. , 1957; Molander et^  al^. , 1957; Wor-
blewskl , 1959) and may be indicative of l iver d iseases . Acute hepatitis 
is distinguished from other l iver diseases in that the GPT rise is more 
than that of GOT (De Ritis et^ aA_. , 1956). Wroblewski (1959) stated that 
hepatic c i r rhos is causes moderate increase in both the transaminases. The 
value is higher in the decompensated than in compensated form of cirrhosis . 
Thus i t is of interest to correlate the serum transminase levels 
in leprosy with histological al terat ions in l i ve r . 
In the present study both the enzyme GOT and GPT have a rising 
tendency from TT to LL. There seems to be a direct correlation in the 
serum enzyme level and downgrading of the disease from TT to LL. More 
so, it may also be conjectured that the over pouring of enzymes in the 
blood might be due to the sever i ty of the disease in the l iver . In TT 
pa t ien t ' s l iver the involvement is negligible whereas the l iver in LL pa-
tients is one of the r ichest sources of lepra bacill i growth. Hence the 
serum enzyme changes in the blood may be due to over pouring of these 
enzymes accordingly in the blood. The lower values of GOT and GPT spe-
cially in case of BT patient recorded during the present study has remained 
largely unexplained, and might be due to case variat ion, history of the 
disease, pa t ien t ' s treatment and such other factors. 
These observation suggested that the re la t ive rise in level of 
SGOT and SGPT, seen in lepromatous leprosy, indicate a toxic effect of 
leprosy bacil l i on the hepatic ce l l s . 
Enzyme lactic dehydrogenase (LDH) is usually found in the soluble 
compartment of cells (Ogawa, 1967) which catalyses the interconversion 
M 
of pyruvic acid and is an essential enzyme in both anaerobic and aerobic 
glycolysis (Coodley, 1970). 
In progressive cases of lepromatous type the variabili ty of the 
total act ivi ty of LDH in serum was remarkable and i ts activity in one 
case increased to 2-fold compared with control serum level (Saito, 1972). 
Our observations during the present study was in complete agree-
ment with Saito (1972). They iiad made the observation that LDH activity 
increases in the blood when the spectrum of the disease is downgrading 
and the double fold r i se in th i s enzyme was noted by them. In the present 
investigation there was pract ical ly no change in the enzyme levels in TT 
and BT cases but in the LL cases there was significant elevation roughly 
estimated to be 2-fold. This might be due to the severi ty of the disease 
in LL patients which might be leading to the cell damage and release 
of these enzymes. The values of the acid phosphatase have normally not 
shown any significant change over controls in the present study. Since 
there is slow but continuous diffusion of th is enzyme in the blood. It 
might not be raised in leprosy cases over the normal persons. 
Enzyme acid phosphatase which provides a direct measure of 
lysosomal act ivi ty in the lepra cells has been demonstrated by the use 
of histochemical techniques (Brieger and Allen, 1962). 
Patterson (1959) reported that there was a slow but continuous 
diffusion of phosphatases above normal rate in those patients of leprosy, 
who showed specific destruct ive bony lesions. Dhople and Magar (1962) 
also observed gradual increase in phosphatase act ivi ty with the severity 
of the disease in each type of leprosy though the value for acid phospha-
tase were within normal l imits . 
Serum acid phosphatase shows a raised level in it specific acti-
vity in Dimorphous (BB & BL) and Tuberculoid (TT & BT) types of cases 
against control value contrary to th is the specific act ivi ty of serum acid 
phosphatase in LL cases s l ight ly decreased against control value. Our 
observations are contrary to observation reported by Dhople and Magar 
(1962). 
Serum alkaline phosphatase values were found to be within normal 
range .(Dhople & Magat , 1962; Ramu and Nagarajan , 1962; Mukherjee & Ghosh, 
1973; Kapoor & Gupta, 1974). 
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In the present s tudy, a rising trend has been obtained in the 
specific act ivi ty of serum alkaline phosphatase in different clinical grades 
of leprosy. But a lower value for TT cases over controls has also been 
obtained. Although increased values of alkaline phosphatases have been 
obtained in BT, BB and BL cases , but again sudden decline has been obser-
ved in LL cases . The extreme polar variation (TT & LL), i . e . lower values 
in both cases is unexplainable as to why at least it decreases in LL pa-
t ients . 
Villela (1938) expresses the possibi l i ty of changes in phosphatase 
act ivi ty in advanced cases of leprosy , possibly due to disturbed power 
to hydrolyse phosphate esters by plasma. 
SUMMilRY 
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Serum enzyme profile was studied in 80 patients with different 
clinical grades of leprosy and compared with that of 25 healthy controls. 
The enzyme studied were SCOT, SGPT, LDH (Total) , acid and alkaline 
phosphatase. SCOT, shows a decreasing trend from TT to BL but an eleva-
ted level has been found in LL cases as compared to normal. Contrary 
to this an increasing pattern was recorded in the case of SGPT from 
TT to LL against control value, except TT which shows a decreased level 
over control. Serum LDH (Total) was found significantly elevated in BB, 
BL and LL but there is no significant difference in TT and BT when com-
pared with the control values. Serum acid and alkaline phosphatases 
showed fluctuating trend in different grades of leprosy against normal 
control values. 
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